Skip to main content
eLife logoLink to eLife
. 2026 Jan 23;14:RP105214. doi: 10.7554/eLife.105214

Computational modelling identifies key determinants of subregion-specific dopamine dynamics in the striatum

Aske Ejdrup 1,, Jakob Kisbye Dreyer 2, Matthew D Lycas 1, Søren H Jørgensen 1, Trevor W Robbins 3,4, Jeffrey Dalley 3,4,5, Freja Herborg 1,†,, Ulrik Gether 1,†,
Editors: Roshan Cools6, Michael J Frank7
PMCID: PMC12829992  PMID: 41574574

Abstract

Striatal dopamine (DA) release regulates reward-related learning and motivation and is believed to consist of a short-lived phasic and continuous tonic component. Here, we build a large-scale three-dimensional model of extracellular DA dynamics in dorsal (DS) and ventral striatum (VS). The model predicts rapid dynamics in DS with little to no basal DA and slower dynamics in the VS enabling build-up of tonic DA levels. These regional differences do not reflect release-related phenomena but rather differential dopamine transporter (DAT) activity. Interestingly, our simulations posit DAT nanoclustering as a possible regulator of this activity. Receptor binding simulations show that D1 receptor occupancy follows extracellular DA concentration with milliseconds delay, while D2 receptors do not respond to brief pauses in firing but rather integrate DA signal over seconds. Summarised, our model distills recent experimental observations into a computational framework that challenges prevailing paradigms of striatal DA signalling.

Research organism: Mouse

Introduction

Striatal dopamine (DA) release is essential for regulating reward-related learning, incentive motivation, and motor function (Berke, 2018; Klaus et al., 2019). DA exerts these roles over a broad range of time scales, yet DA primarily operates as a volume transmitter that targets metabotropic receptors located within a micrometre range from the sites of release (Agnati et al., 1995; Borroto-Escuela et al., 2018; Cragg and Rice, 2004; Gonon et al., 2000; Sulzer et al., 2016). The temporal and spatial dynamics of DA release in the striatum, however, remain a highly contested topic. Classically, DA release has been divided into tonic release, driven by pacemaker-like spontaneous firing, and phasic release from coordinated bursts of firing across neurons (Niv et al., 2007; Schultz, 2007; Sulzer et al., 2016). However, this sharp distinction in release modes, as well as the existence of a basal DA level, has recently been challenged (Berke, 2018; Ejdrup et al., 2023; Jørgensen et al., 2023; Liu et al., 2021; Sippy and Tritsch, 2023).

The picture is further complicated by major regional differences across striatal subdomains. These include differences in Ca2+-channel and nicotinic acetylcholine receptor (nAChR) expression profiles on DA terminals, as well as differential regulation and expression of the DA transporter (DAT; Brown et al., 2011; Cardozo and Bean, 1995; Kearney et al., 2023; Richards and Zahniser, 2009; Threlfell et al., 2010). In addition, we and others have found remarkable differences in extracellular DA release dynamics between the dorsal (DS) and ventral striatum (VS; Jørgensen et al., 2023; Mohebi et al., 2024; Salinas et al., 2023). Fibre photometry recordings in the DS in mice using the DA sensor dLight1.3b during self-paced exploratory activity showed a rapidly fluctuating signal, whereas we observed up to minutes-long DA dynamics in VS that correlated with behavioural output (Jørgensen et al., 2023). Concurrent measurements of extracellular DA by microdialysis and fibre photometry have furthermore corroborated the lack of tonic levels of DA in DS while supporting its presence in VS (Ejdrup et al., 2023; Jørgensen et al., 2023). Despite these reported differences in striatal DA dynamics, electrophysiological recordings suggest that DA neurons from the primary innervators of DS, substantia nigra par compacta (SNc) and VS, ventral tegmental area (VTA), have remarkably similar firing patterns at rest (Dodson et al., 2016). We therefore set out to better understand the fundamental principles governing extracellular DA dynamics by constructing a new computational model of the striatal DA system.

Extracellular DA dynamics have been modelled before; either one-dimensionally or with a primary focus on single release events or post-synaptic receptor binding (Beyene et al., 2017; Dreyer et al., 2010; Dreyer and Hounsgaard, 2013; Dreyer et al., 2016; Venton et al., 2003; Wiencke et al., 2020). Here, we present a three-dimensional model of tens of thousands of release sites, focused on larger-scale signalling and based on experimentally observed biological parameters. The model faithfully replicates experimentally observed results as well as the difference in DA dynamics between DS and VS. Importantly, it offers compelling evidence that these differences do not primarily reflect different release phenomena but rather arise from differential expression and possibly nanoscale localisation of the DAT.

Results

Construction of a model of DA dynamics in the striatum

We constructed a novel model of DA release using experimentally determined parameters from DS, including release, uptake, and cytoarchitecture (Doucet et al., 1986; Dreyer et al., 2010; Dreyer and Hounsgaard, 2013; Liu et al., 2021; Olson et al., 1972; Sulzer et al., 2016). DA release sites on axons projecting from the midbrain were randomly simulated as uniformly distributed discrete points in a three-dimensional space (Figure 1A). The release events themselves were simulated as point source events (Cragg and Rice, 2004) driven by action potentials (AP). We then modelled DA release for each voxel in the simulation containing a release site as a function of three key parameters: firing rate, release probability, and quantal size:

releasen,t=Poisson(fratedt)nP(R%)tQdt (1)

Figure 1. Large-scale 3D model of the dorsal striatum.

(A) Self-enveloped simulation space of 100 µm3 with approximately 40,000 release sites from 150 neurons. Colours of individual release sites are not matched to neurons. (B) Simulation of a single release event after 5 ms and 10 ms. Colour-coded by DA concentration. (C) Comparison of analytical solution and simulation of diffusion after a single release event at three different time points. (D) Representative snapshot of steady state DA dynamics at 4 Hz tonic firing with parameters mirroring the dorsal striatum. (E) Cross-section of temporal dynamics for a midway section through the simulation space shown in (d). (F) Histogram of DA concentrations ([DA]) across the entire space in (d). (G) DA release during three burst activity scenarios for all release sites in a 10 x 10 × 10 µm cube (black boxes) and spill-over into the surrounding space. Burst simulated as an increase in firing rate on top of continued tonic firing of the surrounding space. Traces on top are average DA concentrations for the marked cubes, with bursts schematised by coloured lines below. The first image row is at the end of the burst, and the second row is 100 ms after. Scale bars for traces are 200 ms and 500 nM. Scale bar for the images is 20 µm. (H) Top: representative [DA] trace for a voxel with a release site during pacemaker and burst activity. Bottom: Occupancy of D1Rs and D2Rs for the same site. (I) Zoom on a DA burst as in (h), with [DA] in blue and D1R occupancy in teal with line style indicating different affinities. The shaded area indicates the period of bursting with 6 APs at 20 Hz. (J) Effect of complete pause in firing for 1 s on both average [DA] and D1R and D2R occupation.

Figure 1—source code 1. Source code used to generate data in A, D, E, and F.
Figure 1—source code 2. Source code used to generate data in B and C.
Figure 1—source code 3. Source code used to generate data in G.
Figure 1—source code 4. Source code used to generate data in J.
Figure 1—source code 5. Source code used to generate data in H.
Figure 1—source code 6. Source code used to generate data in I.

Figure 1.

Figure 1—figure supplement 1. Average concentration and receptor kinetics.

Figure 1—figure supplement 1.

(A) Average DA concentration across a 100 x 100 × 100 µm volume of simulated DS at pacemaker activity. (B) Mean concentration change in response to a single event with 60% release probability (see supplementary notes on electrical stimulation) in all neurons at time zero. Blue trace is output directly from simulation, grey trace is the predicted FSCV measurement. (C) Modelling of predicted FSCV measurement and representative snapshot of simulation space just after a release event. (D) Peak DA concentration reached at different distances from the area with phasic activity for the three firing scenarios. (E) Volume of space exposed to greater than 100 nM DA after firing relative to volume of space where terminals actively burst. (F) Least-squares fit linear regression of the dLight and GRABDA sensors based on reported kinetics (Labouesse and Patriarchi, 2021) and newest experimental characterisation of D2R (Ågren et al., 2021). Shaded areas indicate 95% C.I. (G) Top: representative [DA] trace for a voxel with a release site during pacemaker and a triple burst scenario (300 ms long bursts of 3 APs at 10 Hz, three times in a row with 300 ms in between). Bottom: Occupancy of D1Rs and D2Rs for the same site. (H) Effect of complete pause in firing for 1 s on both average [DA] and D2R occupation at different affinities.
Figure 1—figure supplement 1—source code 1. Source code used to generate data in Figure 1—figure supplement 1.
Figure 1—figure supplement 2. Simulation size and granularity.

Figure 1—figure supplement 2.

(A) Schematic of different simulation sizes. (B) Concentration percentiles at different simulation diameters. Results are not robust until a diameter close to 50 µm is reached (line runs behind 100 µm line). (C) Schematic of simulation granularity. (D) Effect of simulation voxel diameter on concentration percentiles. Virtually no difference in concentration profiles below the 99.9th percentile of [DA], with the 1.0 µm voxel size still following 0.1 and 0.5 µm well above that level. The inset shows 99.75th to 100th percentile with y-axis matching main y-axis. (E) Absolute difference in [DA] between simulations at 0.1 µm voxel diameter and 0.5, 1.0, and 2.0 µm. The inset shows 99th to 100th percentile with y-axis matching main y-axis. (F) Percentage difference in [DA] between simulations at 0.1 µm voxel diameter and 0.5, 1.0, and 2.0 µm.
Figure 1—figure supplement 2—source code 1. Source code used to generate data in Figure 1—figure supplement 2.
Figure 1—video 1. Representative video of steady-state dynamics at 4 Hz tonic firing in a 100 x 100 × 100 µm volume with parameters mirroring those experimentally observed in dorsal (left) and ventral (right) striatum.
Download video file (6.6MB, mp4)
Slowed down 10 x for illustrative purposes.
Figure 1—video 2. Representative video of a cross-section of a burst firing of 6 action potentials (AP) at 20 Hz the centre of the plane (circle) for the dorsal (upper row) and ventral (bottom row) striatum during steady state dynamics at 4 Hz tonic firing.
Download video file (953.5KB, mp4)
The left column shows DA concentration, middle D1 occupancy and right D2 occupancy. The scale bar in the upper left-hand field shows 10 µm and is kept identical for all views. Slowed down 15 x for illustrative purposes.

where Poisson(fratedt)n is a Poisson distribution of action potentials (AP) for the given neuron (n) with the firing rate frate(l), P(R%)t is the probability of release at the individual terminal (t) for each AP, while Q is the number of DA molecules released per event (dopaminergic quantal size) and dt the time step. Changing frate can be used to model both pacemaker firing, typically reported at 2–10 Hz, and burst firing, which can exceed 20 Hz (Sulzer et al., 2016).

DA reuptake in the striatum is almost exclusively mediated by the DAT (Jones et al., 1998), which is widely distributed along DA axons and varicosities (Block et al., 2015; Eriksen et al., 2010; Eriksen et al., 2009). As reuptake follows concentration-dependent Michaelis-Menten kinetics (Nicholson, 1995), we simulated uptake as follows:

uptake=Vmax[DA]Km+[DA]dt (2)

where [DA] is the concentration of DA for each voxel in the model, Vmax is the maximal uptake capacity in the region and Km is the concentration of DA at which half of Vmax is reached.

The spatial distribution of released DA is a complex interplay between release, uptake, and diffusion. Diffusion in an open 3D space can be simulated for each voxel with a Laplacian operator:

diffusion=DAx,y,z,tt=Dadt(2DAx,y,z,tx2+2DAx,y,z,ty2+2DAx,y,z,tz2) (3)

where Da is a corrected diffusion coefficient and dt is the timestep. As the extracellular space of the striatum is tortuous, we modified the conventional diffusion coefficient D to an apparent diffusion coefficient (Da) to correct for the tortuosity (λ) of the striatum (Cragg and Rice, 2004; Nicholson, 1985):

Da=Dλ2 (4)

As the cerebellum exhibits a tortuosity similar to that recorded in the striatum, we assumed a uniform tortuosity throughout the striatum (Nicholson and Phillips, 1981). Combining Equations 1–4, we model DA changes in each voxel with a single conceptual equation:

dDAdt=releaseuptake+diffusion (5)

We first compared our 3D model of DA dynamics to the analytical solution of a single release event (Cragg and Rice, 2004; Gonon et al., 2000). To do this, we simulated a quantal event of 3000 DA molecules and calculated DA concentrations across space at three separate time points (Figure 1B and C). The analytic solution and our model predicted almost identical results. Slight differences were introduced as the analytical solution assumes linear uptake from DAT while our model incorporates non-linear Michaelis-Menten kinetics. These differences, however, were almost negligible. The main difference between the two models lies in scalability across both space and time. Summarised, the model enables a dynamic incorporation of the surrounding DA concentration, release events, and uptake and can be scaled to cover DA dynamics of a large 3D space, whose size and granularity is only limited by computing power (see Code Availability Section for the Python code with numerical implementations of the equations listed and scripts to run the simulations and plot the main figures).

We also tested the validity of our model by examining the response to electrical stimulation. Importantly, our model faithfully mirrored DA release seen with fast-scan cyclic voltammetry (FSCV) recordings upon direct stimulation of striatal slices when we corrected for kinetics of the typical FSCV recording setup (Figure 1—figure supplement 1A, B and Appendix 1 - supplementary text) (Atcherley et al., 2015; Brimblecombe et al., 2019; Stuber et al., 2010; Xie et al., 2020).

Simulating large-scale DA dynamics of the dorsal striatum

To better understand the extracellular DA dynamics that arise from the balance between dopaminergic pacemaker activity and uptake, we simulated DA dynamics in the DS generated by pacemaker activity (4 Hz) of 150 neurons in the midbrain in a 100 x 100 × 100 µm space (Figure 1D, see parameters in Table 1). Our simulations yielded a pattern of partially segregated DA hot spots with large fractions of the simulated space devoid of DA, suggesting that release events in DS only elevate DA in the immediate surroundings, with DAT-dependent clearance preventing a larger spread in space (Figure 1D and Figure 1—video 1). This was also illustrated by a cross-section in time (Figure 1E). In line with our recent in vivo microdialysis experiments, the average DA concentration in the simulations during pacemaker activity was approximately 10 nM (Ejdrup et al., 2023). Further, when we calculated the average concentration of a larger area across time, which fibre photometry conceivably does, the results resembled a tonic DA concentration (Figure 1—figure supplement 1C). However, our model predicted a spatial distribution that is highly heterogenous and devoid of pervasive resting or tonic DA levels (Figure 1D–F).

Table 1. List of variables used in the simulation of the dorsal striatum.

Variable Abbreviation Value Reference
Firing rate 4 Hz Paladini et al., 2003
Release probability 6% Dreyer et al., 2010
DA molecules per vesicle 3000 Klaus et al., 2019
Diffusion coefficient 763 µm2 s-1 Nicholson, 1995
Tortuosity 1.54 Rice and Nicholson, 1991
Vmax 6.0 µm s-1 See Appendix 2—table 2
Km 210 nM Hovde et al., 2019
Active terminal density - 0.04 µm-3 Liu et al., 2021
Extracellular volume fraction 0.21 Rice and Nicholson, 1991
Number of neurons in simulation space - 150 Matsuda et al., 2009

To ensure our simulations were performed within a sufficiently large space to yield consistent results, we tested different sizes of the simulated area and found a diameter of 50 μm to faithfully mimic the results of larger simulations (Figure 1—figure supplement 2A, B). Additionally, we tested our simulations at different granularity (0.1, 0.5, 1, and 2 μm). The finer the spatial grain, the higher the detail close to a release event; however, at a spatial granularity of 1 μm, [DA] deviated by <2% across most percentiles and only by >1 nM above the 99.5th percentile (Figure 1—figure supplement 2C-F), leading us to use this voxel size for our simulations.

Burst firing and receptor occupancy

DA neurons are known to fire short bursts of APs, which is a phenomenon strongly linked to reward-prediction error and learning (Schultz, 2007). These bursts can also be induced locally in the striatum by nicotinic receptor activation (Liu et al., 2022; Matityahu et al., 2023). To gain insights into extracellular DA dynamics following a locally induced burst, we simulated three different firing scenarios for a group of terminals within a 10 x 10 × 10 µm field encompassing roughly 40 release sites from the randomly simulated 150 neurons: 3 pulses at 10 Hz, 6 pulses at 20 Hz, and 12 pulses at 40 Hz (Figure 1G – burst properties matched to be the same duration). The middle scenario most closely resembles the physiological burst behaviour reported in the literature, whereas the high-activity burst is above what is typically seen. Unsurprisingly, peak DA concentration was reached at the end of the bursts (Figure 1G). The 3 APs/10 Hz bursting scenario generated no significant spill-over of DA outside the region of activity, whereas the 6 APs/20 Hz and 12 APs/40 Hz bursting scenarios markedly overwhelmed uptake (Figure 1G). The relationship between firing rate and the sphere of influence by DA became further evident when plotting maximal concentration of the surrounding space (Figure 1—figure supplement 1D) and the volume of space with a DA concentration above 100 nM (Figure 1—figure supplement 1E). We found that the 3 APs/10 Hz stimulation produced DA responses that largely resembled that of a single pulse. In both cases, DA was mostly cleared after 100ms and the volume exposed to greater than 100 nM was similar (Figure 1G, Figure 1—figure supplement 1E). In contrast, the high bursting activities caused a frequency-dependent spill-over, where the areas exposed to a DA concentration above 100 nM were 10 and 30 times larger than the terminal origin for 6 APs/20 Hz and 12 APs/40 Hz, respectively. Even after 100ms, a considerable amount of DA remained in the 12 APs/40 Hz scenario (Figure 1G).

To understand how these DA dynamics could affect the postsynaptic response, we modelled receptor binding. D1 receptors (-Rs) were assumed to have a half maximal effective concentration (EC50) of 1000 nM, and we extrapolated the reverse rate constant (koff) to 19.5 s–1 based on a linear fit of the recently characterised DA-receptor-based sensors (Figure 1—figure supplement 1E; Labouesse and Patriarchi, 2021). We set the EC50 of D2Rs to 7 nM and koff to 0.2 s–1 based on the DA sensor kinetic fit (Figure 1—figure supplement 1F), which matches a recent binding study (0.197 s–1 for binding study vs. 0.204 s–1 based on linear fit), indicating the receptor-based sensor fit can be extrapolated to the endogenous receptors (Ågren et al., 2021). To determine how these receptors would respond to our predicted DA dynamics, we simulated pacemaker activity at 4 Hz with an added burst of 6 APs/20 Hz. Figure 1H shows a representative trace of DA concentration and occupancy of the D1R and D2R for a voxel with a release site. During pacemaker activity, D1R showed an occupancy close to 0, whereas D2R occupancy was approximately 0.55 (Figure 1H). Both D1R and D2R occupancies were due to a high diffusion rate mostly invariant to individual release events caused by pacemaker activity. However, upon coordinated burst firing, the occupancy rapidly increased (Figure 1H and Figure 1—video 2) as diffusion no longer equilibrates the extracellular concentrations on a timescale faster than the receptors. D1R receptor occupancy closely tracked extracellular DA with a delay of only ~50 ms for the typically reported affinity of 1 µM (Figure 1I). By contrast, it took at least 5 s before the burst-induced increase in D2R occupancy had declined to baseline levels (Figure 1H and Figure 1—video 2). This made the D2R incapable of temporally separating closely linked bursts of activity and rather summarised the output, whereas the D1R occupancy reset between each individual burst (Figure 1—figure supplement 1G). Perhaps more surprisingly, the D2R occupancy only fell from approximately from 0.55 to 0.45 when simulating a full second pause in firing due to the slow off kinetics (Figure 1J). Indeed, this finding was robust across an order of magnitude of D2R affinity (2 nm - 20 nM), although the sensitivity to a one-second pause was larger at an affinity of 20 nM (Figure 1—figure supplement 1H).

These simulations suggest that the dopaminergic architecture of the DS limits DA overflow during physiologically relevant bursting activity. Further, DA receptors had a temporally mostly uniform response to DA release caused by pacemaker activity, with D1R occupancy responding rapidly to both onset and offset extracellular DA concentrations following bursts, while D2R showed seconds-long delays in offset.

Ventral striatum maintains pervasive DA tone

Mounting evidence points to considerable differences in DA dynamics across striatal subregions (Jørgensen et al., 2023; Mohebi et al., 2024), which might reflect differences in the cytoarchitectural and/or molecular dopaminergic makeup. In line with this, most studies report lower dopaminergic density in the VS than in DS regardless of methodological modality with a median value of ~90% in VS relative to DS (Appendix 2—table 1). Further, DAT-mediated uptake capacity is reported to be lower in VS with a median capacity at ~30% of DS (Appendix 2—Tables 1 and 2). Consistently, we observed a clear dorsoventral gradient for DAT expression when analysing immunostainings in striatal mouse brain slices from a previous publication (Sørensen et al., 2021; Figure 2—figure supplement 1A, B). By contrast, the VMAT2 staining only decreased slightly from VS to DS (Figure 2—figure supplement 1A–C).

We simulated DA release during pacemaker activity in both DS and VS. DS values were set as previously described (25 µm3 per terminal, uptake capacity of 6.0 μM s–1), but for VS we reduced the terminal density to 90% (27.8 µm3 per terminal) and DAT uptake capacity to 33% (2.0 µM s–1) (Appendix 2—Tables 1 and 2). The remaining parameters were kept identical. With these two differences, our simulations revealed markedly different spatiotemporal DA distributions during pacemaker activity. While DS formed segregated domains with low DA concentrations in the inter-domain space (Figure 2A and Figure 1—video 1), DA diffused further throughout the simulated space in VS, before being cleared by DAT. This gave rise to what may be considered a tonic DA level with hotspots of higher DA concentrations, although the concentration distribution is continuous (Figure 2A–C and Figure 1—video 1).

Figure 2. Regional differences in uptake greatly impact DA dynamics.

(A) Representative snapshots of steady state dynamics at 4 Hz tonic firing with parameters mirroring the dorsal (left) and ventral striatum (right). (B) Cross-section of temporal dynamics for data shown in a. The bottom row shows concentrations of the dashed lines in the top panels. (C) Normalised density of DA concentration of simulations in (a). Thick lines are for the entire space, and thin lines are across time for five randomly sampled locations. Dashed red line is for simulation of the ventral striatum with lowest reported innervation density in the literature. (D) Same data as in (c), but for concentration percentiles. Note that even the lowest percentiles of VS were above 10 nM in [DA]. (E) Convolved model response (Figure S1c) to mimic FSCV measurements mirroring the experimentally tested stimulation paradigm in May and Wightman, 1989 for the dorsal (left) and ventral striatum (right) (F) DA release during three burst activity scenarios for all release sites in a 10 x 10 × 10 µm cube (black boxes) and spill-over into the surrounding space. Burst simulated as an increase in firing rate on top of continued tonic firing of the surrounding space. Traces on top are average DA concentrations for the marked cubes, with bursts schematised by coloured lines below. The first image row is at the end of the burst, and the second row is another 100 ms after. Scale bars for traces are 200 ms and 500 nM. Scale bar for the images is 20 µm. (G) Top: representative [DA] trace 1 µm away from a release site during pacemaker and burst activity. Bottom: Occupancy of D1Rs and D2Rs for the same site. Occupancy data from the corresponding DS simulation on Figure 1k shown as a dotted line. (H) Peak occupancy at different distances from the area bursting, normalised to maximal and minimum occupancy.

Figure 2—source code 1. Source code used to generate data in A-F.
Figure 2—source code 2. Source code used to generate data in G and H.

Figure 2.

Figure 2—figure supplement 1. Histochemical gradient of DAT and VMAT2 fluorescence.

Figure 2—figure supplement 1.

(A) Representative image of the mouse striatal slices analysed in B. Dashed white line indicates the quantified dorsoventral gradient (length 2 mm). (B) Relative intensity of the DAT and VMAT2 immunosignal in the dorsoventral axis of striatal mouse brain slices from Sørensen et al., 2021. All slices show a drop at the anterior commissure (AC). Shaded areas around lines denote S.E.M. (C) Mean relative intensity of the DAT and VMAT2 signal before and after AC. Two-sided t-test, VS-DAT:VMAT2, p=0.012(*), n=4 mice; one-sided t-tests, DAT-DS:VS, p=0.0021(**), VMAT2-DS:VS, p=0.0086(**), n=4 mice. (D) Peak DA concentration reached at different distances from area with phasic activity for the three firing scenarios in VS. (E) Volume of space in VS exposed to greater than 100 nM after firing relative to volume of space where terminals actively burst. (F) Effect of complete pause in firing in VS for 1 s on both average [DA] and D1R and D2R occupation.

We compared our model of the two regions with existing experimental data. In an earlier study by May and Wightman, 120 stimulus pulses were delivered in the medial forebrain bundle (MFB) at either 10, 30, or 60 Hz and DA responses were recorded by FSCV in both caudate-putamen (CPu) and nucleus accumbens (Nac; May and Wightman, 1989). To mirror this, we simulated 120 action potentials at similar frequencies (10, 30, and 60 Hz) at 6% release probability and ran the result through convolution, as in Figure 1—figure supplement 1A and B, to generate an FSCV read-out (Figure 2E). Since May and Wightman reported no significant difference in DA released per electrically delivered pulse ([DA]p) between VS and DS, we applied equal quantal size and R% for DS and VS in our simulations, while uptake capacity in VS was kept to a third of DS and terminal density was set to 90% as specified above. Importantly, our simulated FSCV data closely resembled the earlier findings, with VS reaching considerably higher DA levels for all three stimulation frequencies (Figure 2E – see May and Wightman, 1989). This regional difference presumably arises from differences in DAT capacity between DS and VS, as the lower terminal density in VS would have the opposite effect (see below) and the remaining parameters were held identical.

To compare with our results for DS, we tested how VS responded during simulated burst activity. Using firing patterns identical to the DS simulations (Figure 1G), we found a larger spill-over of DA into the surrounding areas in VS (Figure 2F, Figure 2—figure supplement 1D, E). Significant amounts of extracellular DA also remained 100 ms after the physiologically relevant 6 APs/20 Hz firing stimulus. At the receptor level, D1R occupancy in VS showed a similar response to that in DS during the burst (Figures 1I and 2G and Figure 1—video 2). By contrast, D2R occupancy during pacemaker activity was higher in VS than DS (~0.8 versus ~0.55 in DS), in accordance with the higher prevailing basal DA concentration. Additionally, the larger DA overflow in VS after a burst caused a higher relative increase in receptor occupancy further away from the area actively bursting than compared to DS (Figure 2H). A pause in firing had the same effect on D2R as in DS (Figure 2—figure supplement 1F).

Changes to uptake capacity greatly affect [DA] in the ventral striatum

The values used to model the striatum (Table 1) in the previous simulations were chosen to best mimic the physiological system found in vivo. However, to test the robustness of the results, we performed simulations across wide ranges of the variable key parameters on which the model is based. First, we varied the number of varicosities actively releasing DA by setting the varicosity density to one site per 9 µm3 (Doucet et al., 1986) and simulating 4 Hz pacemaker activity with the release-capable fraction ranging from 5% to 100% (reported values range from 20% to virtually all) (Ducrot et al., 2021; Liu et al., 2021; Liu et al., 2018; Pereira et al., 2016; Figure 3A). As the fraction of active sites increased, DA concentrations increased at both the median level (50th percentile), which we consider a measure of tonic or baseline DA levels, and at peak levels (99.5th percentile) in both DS and VS (Figure 3B, see Figure 3—figure supplement 1A for schematic of tonic and peak DA). We then used the 99.5th/50th percentile ratio as a measure of the focality of the DA distribution (i.e. hotspot DA relative to baseline DA). This was intended as a measure of heterogeneity, that is, the higher focality, the greater competence for spatially heterogenous signalling, as has been reported in Hamid et al., 2021; Howe and Dombeck, 2016. Quantifying this across the percentage of active terminals showed that the focality of the DA distribution dropped as the active fraction increased in both regions (Figure 3C). However, the percentage of active sites in VS needed to drop to 5% to reach a relative distribution resembling the DS at a full 100% active sites, underscoring a marked difference in the spatial confinement of DA signals in VS and DS.

Figure 3. Sensitivity of the model to parameter changes.

(A) Schematic of the fraction of active release sites. Black dots are inactive sites, and green dots indicate actively releasing sites. (B) Effect of changing fraction of active release sites on DA concentrations. Blue line, DS peak DA concentration (99.5th percentile); Red line, VS peak DA concentration (99.5th percentile); Dotted blue line, DS tonic DA concentration (50th percentile); Dotted red line, VS tonic DA concentration (50th percentile). (C) Ratio between peak (99.5th percentile) and tonic (50th percentile) concentrations across fractions of active release sites in the DS (blue line) and VS (red line) as a measure of DA signal focality. (D) Schematic of changing quantal size (Q). (E) Effect of changing quantal size on tonic and peak DA concentrations in DS (blue lines) and VS (red lines). (F) Ratio between peak and tonic concentrations across various quantal sizes in in DS (blue line) and VS (red line). (G) Relative difference between the DS and VS for peak (black line) and tonic DA (dotted line) at different quantal sizes. (H) Schematic of changing DAT Km. (i) Effect of changing DAT Km on DA concentrations in DS (blue lines) and VS (red lines). (J) Schematic of changing DAT Vmax. (K) Effect of changing DAT Vmax on DA concentrations. Shaded areas are median Vmax of the two regions (DS and VS) as found in the literature shown in Appendix 2—table 2 ± 50%. (L) Effect of changing DAT Vmax, with tonic (50th percentile) and peak (99.5th percentile) DA concentrations normalised to their value at 2 µm s–1 (median value for VS). The shaded area indicates median Vmax for VS found in the literature shown in Appendix 2—table 2 ± 50%.

Figure 3—source code 1. Source code used to generate data in B, C, E-G.
Figure 3—source code 2. Source code used to generate data in I.
Figure 3—source code 3. Source code used to generate data in K and L.

Figure 3.

Figure 3—figure supplement 1. Model parameter testing.

Figure 3—figure supplement 1.

(A) Schematic of our definitions of tonic (50th percentile/median, dashed lines) and peak (99.5th percentile, solid line) DA for both the dorsal and ventral striatum. (B) Effect of changing release probability (R%) on DA concentrations. (C) Relative difference between the ventral and dorsal striatum at different percentiles for different release probabilities. (D) Ratio between 99.5th and 50th percentiles as a measure of focality for both regions. As R% increases, the concentrations become more homogeneous. (E) Effect of changing firing rate on DA concentrations. (F) Relative difference between the ventral and dorsal striatum at different percentiles for different firing rates. (G) Ratio between 99.5th and 50th percentiles for both regions. As the firing rate increases, the concentrations become more homogeneous.
Figure 3—figure supplement 1—source code 1. Source code used to generate data in Figure 3—figure supplement 1.
Figure 3—figure supplement 2. Fold change during inhibition, Vmax-sensitivity at different release parameters and release-uptake balance.

Figure 3—figure supplement 2.

(A) Fold change over baseline (Km of 210 nM) for mean DA concentration in the dorsal (DS) and ventral striatum (VS) with changing DAT Km. (B) Relative difference between the dorsal and ventral striatum for both phasic and tonic DA at different Km values. (C) Effect of changing DAT Vmax on DA concentrations for three different quantal sizes (Q). [DA] normalised to highest values within each Q. Shaded area indicates median Vmax for DS and VS as found in the literature shown in Appendix 2—table 2 with ±50%. (D) Effect of changing DAT Vmax on DA concentrations for three different release probabilities (R%). [DA] normalised to highest values within each R%. Shaded area indicates median Vmax for DS and VS as found in the literature shown in Appendix 2—table 2 with ±50%. (E) Least-square fit linear regression between release rate and autocorrelation decay rate (τ) (Ejdrup et al., 2023). Shaded area highlights 95% C.I. (F) Partial regression plot error of the regression in (f) and error between DA response to amphetamine as measured by microdialysis and the release rate from Ejdrup et al., 2023 to show that the less release and uptake correlate, the less release rate can explain the microdialysis response, suggesting release and uptake are partially independent of each other. Shaded area highlights 95% C.I.
Figure 3—figure supplement 2—source code 1. Source code used to generate data in Figure 3—figure supplement 2A-D.

The predicted total DA content of a vesicle and the fraction of content released per fusion event is reported to range from 1,000–30,000 molecules (Garris et al., 1994; Pothos et al., 1998; Staal et al., 2004; Sulzer and Pothos, 2000; Figure 3D). As expected, tonic and peak concentrations increased in both DS and VS as quantal size was increased (Figure 3E). Also, as expected, the focality of the DA distributions dropped for both regions as quantal size increased (Figure 3F). The relative difference in tonic DA, however, remained persistently higher in VS and even increased as quantal size increased, indicating a tendency for VS to maintain basal levels of DA regardless of release content (Figure 3G). The higher end of quantal sizes, however, resulted in median concentrations far beyond what is typically reported (Figure 3E; Sulzer et al., 2016). We observed a largely similar pattern when changing either release probability or firing rate (Figure 3—figure supplement 1B-G).

DAT activity is governed by two parameters: Km and Vmax (Kristensen et al., 2011). To mimic competitive inhibition of DAT by, for example cocaine, we ran a simulation across various Km values (Figure 3H) showing that increasing Km caused a linear increase in DA levels, consistent with DAT uptake rate responding almost linearly to increases in [DA] below Km (Figure 3I). Of note, most microdialysis studies have reported that cocaine increases [DA] to the same degree in both DS and VSBEsrt wishes; however, these quantifications are usually derived as a ratio of the absolute baseline level (Carboni et al., 2001; Maisonneuve and Glick, 1992). If we divide our simulations of increasing Km with the basal levels estimated in Figure 3A-C a similar response for DS and VS is found (Figure 3—figure supplement 2A). Further, we observe a convergence on a twofold difference in the absolute values at both tonic and peak levels, which matches reports from earlier FSCV studies (Figure 3—figure supplement 2B; Wu et al., 2001). This regionally differential response to cocaine matches our observations in a previous biosensor-based study (Jørgensen et al., 2023).

Finally, we changed Vmax by ±50% in both regions and observed a smaller change in tonic level in DS (11 nM) than in VS (38 nM) (Figure 3K). This suggests modulation of Vmax has higher impact in VS than DS. Further, the impact of changing Vmax in VS was independent of both Q and R% within values typically reported in the literature (Figure 3—figure supplement 2C, D). In contrast to the changes in tonic levels, the relative effect Vmax had on peak levels was much more modest (Figure 3L).

Changes to uptake rate may be mediated by DAT internalisation pathways, but to our knowledge, there is not in vivo evidence of differential release-uptake balances between animals that could lead to varying tonic DA levels across animals. We therefore reanalysed data from our previously published comparison of fibre photometry and microdialysis (Ejdrup et al., 2023) and found evidence of natural variations in the release-uptake balance of the mice (Figure 3—figure supplement 2E, F), which may underlie different tonic levels of DA in the striatum between animals.

DAT nanoclustering affects steady state [DA] and clearance after bursts

Our simulations highlight DAT Vmax as an effective regulator of extracellular DA levels in VS (Figure 3K). Internalisation of DAT can serve as a mechanism for this control but is a relatively slow process operating on the order of minutes (Kristensen et al., 2011). Interestingly, our recent studies have provided evidence that DAT move laterally in the plasma membrane and transition from a clustered to an unclustered nanoscale distribution in response to excitatory drive and other inputs (Lycas et al., 2022; Rahbek-Clemmensen et al., 2017). This led us to hypothesise that DAT nanoclustering serves as a mechanism for regulating DAT activity on a faster time scale. We speculated that dense nanoclusters of DAT would produce domains of low [DA] due to uptake overpowering diffusion (Figure 4A). As the uptake rate is concentration dependent, this would reduce uptake efficiency (Figure 4B). To address this hypothesis, we simulated a single ellipsoid varicosity of 1.5 μm in length and 800 nm thick with surrounding extracellular space (Ducrot et al., 2021). The surface was unfolded to a square of equal area (Figure 4D), and as 9–16.4% of terminals in the striatum are estimated to be dopaminergic (Hökfelt, 1968; Tennyson et al., 1974), we set the volume of the surrounding space to seven times the varicosity volume. On the surface of the varicosity, we randomly distributed eight DAT nanoclusters (Figure 4C) and ran simulations of how DAT clustering density influenced the DA clearance from the surrounding space. The observed DA concentration in the space surrounding the varicosity shown in Figure 4C is illustrated by the cross-section shown in Figure 4D. Mean DA uptake capacity of the entire space was kept constant at 4 μM s–1 (between the values observed for DS and VS) throughout the simulations, representing a constant amount of DAT molecules on the surface of the varicosity. We only changed the fraction of the surface of the varicosity that was uptake competent by altering the cluster size from small clusters of high density to large clusters of lower density. We ran simulations of eight identical clusters at either 20, 40, 80, or 160 nm in diameter to mirror experimentally observed cluster sizes on DA varicosities, as well as a scenario with DAT fully dispersed (Figure 4E; Lycas et al., 2022; Rahbek-Clemmensen et al., 2017). We first performed a test to see the effect clustering would have at steady state concentrations during pacemaker activity. In the unclustered scenario, average [DA] in the simulation hovered at ~15 nM (Figure 4F). However, upon changing to a clustered architecture, [DA] rapidly increased up to 100% (~30 nM) in just 400 ms depending on the degree of clustering (Figure 4F). We further wanted to test what effect nanoclustering would have on clearance after burst activity. To do this, we set the extracellular space to a [DA] of 100 nM and performed simulations for the same clustering scenarios (Figure 4G). Cluster size dramatically affected clearance time, with the most dense clusters taking almost 400ms to reduce [DA] to 5 nM, compared to just ~200 ms for the unclustered scenario. The hyper-local low-[DA] environment that arose around the dense DAT clusters became apparent when we plotted the [DA] at the centre of a cluster compared to the mean [DA] of the extracellular space (Figure 4H – unclustered also showed a drop from surface of varicosity to mean of extracellular space; see general gradient of [DA] in Figure 4D). For the 20 nm cluster scenario, the clearance was almost entirely limited by how quickly DA diffused to the nanocluster, as the local [DA] dropped to near zero. We originally hypothesised the effect would mainly be due to a depression in [DA] at the very cluster centre, but a concentration profile of the 80 nm cluster scenario revealed the entirety of the cluster was enveloped in a low-[DA] environment (Figure 4I). Accordingly, if DA receptors are located directly next to a dense nanocluster, this effect could feasibly alter the concentration the individual receptors are exposed to.

Figure 4. DAT nanoclustering reduces uptake and shows regional variation.

Figure 4.

(A) Schematic of dense DA cluster. White dots represent individual DAT molecules, and colour gradient the surrounding DA concentration. (B) Effective transport rate dependent on local concentration. (C) Top view of unfolded DA varicosity. Black shapes denote clusters of DAT. A dashed white line indicates placement of cross-section shown in (d). (D) Cross-section showing DA concentration in space surrounding varicosity unfolded in c. The grey line at the bottom is the surface of the varicosity. Colour-coded for DA concentration. (E) Top view from (c), but colour coded for DA concentration immediately above membrane surface at different DAT cluster sizes. (F) Changes in [DA] from 15 nM unclustered (Un.) steady state with constant release after changing to four different cluster size scenarios (ø=diameter). (G) Clearance of 100 nM [DA] for different DAT cluster sizes. (H) Difference between DA concentration at the centre of clusters (or general surface of varicosity for unclustered) and mean concentration of the full simulation space (I) Concentrations across a cross section of a surface with 80 nm diameter clusters. Shaded areas highlight cluster locations. (J) Location of images of the dorsal (DS) and ventral striatum (VS) in striatal slices from mice as imaged in Sørensen et al., 2021 with direct stochastic optical reconstruction microscopy (dSTORM). (K) Two representative DA varicosities from DS and VS with VMAT2 in white and DAT in magenta. Images are 1.5x2 µm (scale bar 0.5 µm). (L) Individual DAT localisations (locs.) from images in (k) coloured by clustering. Black indicates localisation identified as clustered based on DBSCAN with parameters 80 nm diameter and 40 localisations. Grey indicates unclustered localisations. (M) Quantification of clustering across all images in (j) with parameters in (l). Welch’s two-sample t-test, p=0.012(*), n=12 (DS) and 13 (VS). (N) Absolute difference in percentage of clustering as assessed with DBSCAN across a range of parameters. VS has a higher propensity to cluster across cluster sizes typically reported for DAT clusters.

Figure 4—source code 1. Source code for simulation.
Figure 4—source code 2. Source code used to generate data in A-E and G-I.
Figure 4—source code 3. Source code used to generate data in F.

Summarised, the data supports that DAT nanoclusters produce domains of low [DA] as uptake outcompetes diffusion. As transporter uptake is concentration dependent, the overall uptake efficiency is reduced, which in turn may lead to higher extracellular concentrations of DA. The simulations therefore posit DAT nanoclustering as an efficient way to regulate the extracellular levels of both tonic DA and the spatiotemporal [DA] profiles following release.

DAT clusters more in the ventral striatum

As our simulations suggest that nanodomain clustering is a way of regulating uptake, and this may be particularly efficient at controlling extracellular DA in VS, we hypothesised nanoscale clustering would be more prominent in VS. To investigate this, we reanalysed data from a previous publication (Sørensen et al., 2021), where we acquired super-resolution images of coronally sliced striatal sections from mice stained for DAT. For the present study, images were split into DS and VS based on where in the slices they were taken (Figure 4J). DA terminals were identified by vesicular monoamine transporter 2 (VMAT2) expression, and qualitatively, DAT appeared more clustered in VS than DS (Figure 4K). To quantify this, we applied the clustering algorithm Density-Based Spatial Clustering of Applications with Noise (DBSCAN) (Figure 4L). This confirmed a regional difference with more DAT localised clusters when using DBSCAN to identify clusters with scanning diameter of 80 nm in VS compared to DS (Figure 4L and M), and we observed a similar regional difference across the range of cluster sizes typically reported (20–200 nm; Figure 4N; Lycas et al., 2022; Rahbek-Clemmensen et al., 2017) supporting the conclusion that DAT nanoclustering is more prevalent in VS than DS.

Discussion

We developed a three-dimensional, finite-difference computational model to investigate spatiotemporal DA dynamics of striatal subregions in detail. Leveraging prior experimental information on regional differences in dopaminergic innervation density and DAT uptake capacity, our model predicts important differences in dopaminergic dynamics between DS and VS. Strikingly, our simulations suggest that large areas of the DS are effectively devoid of a basal level of DA at pacemaker activity, whereas VS maintain a more homogenous tonic-like basal DA concentration with only small changes in uptake activity powerfully regulating the extracellular DA tone. Furthermore, we modelled receptor binding kinetics and found that D1R binding faithfully followed recently described rapid DA dynamics of the striatum (Ejdrup et al., 2023; Jørgensen et al., 2023; Markowitz et al., 2023), while D2R, with an off-rate of ~5 s, appeared better suited for detecting background tone and integrating prolonged activity (Howe et al., 2013; Jørgensen et al., 2023). Collectively, these observations have important implications for our understanding of striatal function in behaviour, including decoding of inputs from the prefrontal cortex (PFC) and limbic system as well as the influential phasic-tonic model of dopaminergic signalling (Grace et al., 2007; Niv et al., 2007; Schultz, 2007).

It has been assumed for long that there are tonic levels of DA in the striatum (Niv et al., 2007; Schultz, 2007; Sulzer et al., 2016), although the phenomenon has no clear definition (Berke, 2018). Our simulation of DA dynamics in DS during pacemaker activity showed no evidence for a homogenous extracellular distribution. Rather, elevated [DA] was transiently present around release sites during pacemaker activity, with the remaining space mostly depleted of DA. The absence of a general tonic DA level in DS predicted by our model directly supports the notion that DA release sites in DS establish distinct and only partially overlapping DA domains rather than diffuse, tonic DA levels (see Liu et al., 2021). This conclusion aligns with recent data where we found that DA concentrations measured by microdialysis correlate with the average of rapid activity recorded with fibre photometry rather than a baseline DA tone (Ejdrup et al., 2023). Earlier modelling work by Wickens and colleagues predicted pacemaker activity would generate a tonic, uniform concentration (Arbuthnott and Wickens, 2007). But our modelling suggested this is prevented by the significant DA uptake capacity of the DS, as measured by more recent reuptake studies (see Appendix 2—table 2).

In contrast to the DS, our model predicted VS to hold a considerable basal level of DA even in spaces without an immediately adjacent release site. This is conceivably what most refer to as tonic DA. In this study, we quantified tonic DA as the median concentration of the entire space (50th percentile), which appeared significantly higher in VS than DS because of the lower VS uptake capacity. Importantly, this matches the results of our direct in vivo comparison of DS and VS in freely moving mice (Jørgensen et al., 2023), as well as supporting a spatial gradient of time horizons in the striatum previously predicted in a separate work by Wickens et al., 2007 and measured in vivo by Mohebi et al., 2024.

To challenge our model predictions, we performed our simulations across a wide range of parameters. Only changes to Vmax for uptake generated differential responses in the two regions. With release and uptake parameters at values from the literature, VS was at a critical point where minor changes to uptake significantly impacted the tonic levels without any major effect on peak concentrations.

Contrary to our observations, some previous microdialysis experiments have suggested higher basal DA levels in the DS compared to VS (Kuczenski and Segal, 1992; Shen et al., 2004) and have reported two to four times higher [DA] in DS compared to VS (Kuczenski and Segal, 1992; Shen et al., 2004). However, there are disparate observations in the literature (e.g. Carboni et al., 2001 reported 20% higher [DA] in VS Carboni et al., 2001). Moreover, it is important to note that regional comparisons in microdialysis might be confounded by the considerably higher uptake rate in DS. This will increase the extraction fraction and possibly lead to a significant overestimation of the extracellular concentration as compared to a region with lower uptake rate, such as the VS (Chefer et al., 2009).

Our three-dimensional simulations highlight DAT-mediated reuptake as a key mechanism governing striatal DA dynamics and as a key mediator of regional-specific DA dynamics. A physiologically relevant way to regulate uptake capacity is moving DAT to and from the plasma membrane. Indeed, DAT is subject to such regulation and some of these mechanisms may even be exclusive to the ventral region, including protein kinase C-induced DAT internalisation and Vav2 regulation of DAT surface expression (Fagan et al., 2020; Zhu et al., 2015). Chemogenetic Gq-coupled DREADD activation of DA neurons also results in differential DAT trafficking in the two regions (Fagan et al., 2020; Kearney et al., 2023). The findings position DAT regulation as an excellent candidate for changing tonic DA levels in VS, which has been proposed to selectively attenuate afferent drive from the PFC through D2R activation (Grace et al., 2007). Recent studies of D2R-expressing spiny projection neurons (SPNs) in the VS also suggest that the receptor is not fully saturated under basal firing (Lee et al., 2020), matching both our simulations of receptor binding and the notion that tonic DA can be manipulated to alter D2R activation.

If changing uptake capacity is to have a behavioural relevance on a fast timescale, a mechanism to regulate DAT function faster than internalisation must exist. Importantly, the transporter does not only move to and from the surface, but also laterally in the plasma membrane. We have reported that DAT forms nanoclusters in the plasma membrane that dynamically reshape based on excitatory and inhibitory input (Lycas et al., 2022; Rahbek-Clemmensen et al., 2017). Moreover, we have previously shown that cocaine, which both competitively inhibits DAT and reorganises the transporter nanodomains (Lycas et al., 2022), changes the DA signal of the DS to dynamics akin to the VS (Jørgensen et al., 2023). Importantly, our simulations showed that nanoclustering may be an effective way to sequester DAT in a dense domain where uptake overpowers diffusion and, as a result, brings down effective uptake speed through local DA depletion. This is in line with evidence that these DAT nanoclusters are enriched in phosphatidylinositol-4,5-bisphosphate (PIP2), and that metabolism of PIP2 decreases uptake rate of DAT (Lycas et al., 2022; Carvelli et al., 2002). We also found that the nanoclustering phenomenon was considerably more prevalent in VS than in DS. Taken together, these data point to DAT nanoclustering as a way to shape both the spatiotemporal profile of DA release as well as the tonic levels of DA in the striatum – particularly in the VS.

Our incorporation of receptor binding was inspired by important previous modelling work (Dreyer et al., 2010; Dreyer and Hounsgaard, 2013; Hunger et al., 2020). However, earlier models by Dreyer & colleagues assumed instantaneous equilibrium between extracellular DA and receptor occupation, which disregards differences in kinetics of the DA receptors that greatly impact transmission dynamics. While later work by Hunger and colleagues introduced more complex receptor modelling, they based their kinetics parameters on early pharmacological studies, whose values likely would prevent DA receptors from decoding signal below the order of minutes (Burt et al., 1976; Maeno, 1982; Nishikori et al., 1980; Sano et al., 1979). Instead, we based our receptor kinetics on newer pharmacological experiments in live cells (Ågren et al., 2021) and properties of the recently developed DA receptor-based biosensors (Labouesse and Patriarchi, 2021), whose receptor values match well despite different methodological approaches. The biosensors are mutated receptors whose kinetics may not be identical to the endogenous receptors, but only the intracellular domains are altered, with no apparent changes of the binding site (Labouesse and Patriarchi, 2021). Indeed, these biosensors exhibit kinetics that are well aligned with both modelled and experimentally reported extracellular DA dynamics using non-biosensor-based methods (Atcherley et al., 2015; Gonon et al., 2000; Venton et al., 2002). We believe accordingly that our updated parameters are more accurate portrayals of in vivo conditions; however, as shown throughout the study, the affinity values greatly affect the results. Therefore, we find it important that our model will be available to the research community, allowing others to test their own estimates of receptor kinetics and assess their impact on the model’s behaviour.

The presented simulations suggested that receptor binding was largely invariant to single release events during pacemaker activity, while bursts of activity rapidly changed occupancy. Both D1R and D2R immediately responded to burst onset; however, while D1R occupancy rapidly declined to zero within approximately 50 ms, the slow D2R kinetics resulted in an occupancy decline over ~5 s, returning to the baseline maintained by tonic firing. This means that D1R is better suited to discriminate inputs in rapid succession and allow for postsynaptic decoding of the fast-paced in vivo dynamics described particularly for DS (Ejdrup et al., 2023; Jørgensen et al., 2023; Markowitz et al., 2023). By contrast, our analysis shows that D2Rs integrate DA signals over several seconds. As D1R occupancy is negligible during pacemaker activity and D2R kinetics are too slow to pick up rapid changes in DA concentration, our simulations moreover suggest pauses in firing of less than 1 s are not an effective way of signalling for the striatal dopaminergic system. Notably, this finding was apparent even when the D2 affinity was increased an order of magnitude. This challenges the effectiveness of proposed negative reward prediction errors, as even a long pause in firing would have a limited effect on D2 receptor occupation and downstream signalling. This may explain why DA drops during reward omissions are not nearly as prominent as positive signals (Farrell et al., 2022; Greenstreet et al., 2025).

In conclusion, we have developed a three-dimensional model for DA release dynamics and receptor binding that integrates a wealth of experimentally determined parameters and generates responses to electrical and pharmacological input that fits robustly with literature observations. The model offers an important theoretical framework and a predictive tool that can serve as the basis for future experimental endeavours and help guide the interpretation of new as well as older empirical findings on DA signalling dynamics under both physiological conditions and in disease.

Materials and methods

Key resources table.

Reagent type (species) or resource Designation Source or reference Identifiers Additional information
Software, algorithm Python https://www.python.org v3.9.7
Software, algorithm Spyder IDE https://www.spyder-ide.org v5.1.5
Software, algorithm Model code https://github.com/GetherLab/striatal-dopamine-modelling Developed for this work
Strain, strain background (Mus musculus) C57Bl/6 J Details provided in Sørensen et al., 2021 Data used are from Sørensen et al., 2021
Antibody anti-DAT Nt (rat monoclonal) Sigma-Aldrich MAB369
RRID:AB_2190413
IF (1:200)
Sørensen et al., 2021
Antibody Anti-VMAT2
(rabbit polyclonal)
Kind gift from Dr Gary W. Miller, Columbia University Sørensen et al., 2021 IF (1:4000)
Sørensen et al., 2021

Three-dimensional finite difference model

DA release sites in the striatum were simulated at a density of one site per 25 µm3 in DS and one site per 27.8 µm3 in VS (except for Figure 4B and). As a single medium spiny neuron in the striatum is estimated to be influenced by axons from 95 to 194 dopaminergic neurons (Matsuda et al., 2009), we simulated DA release sites as originating from 150 separate cell bodies. These were set to fire independently from each other at 4 Hz generated by a Poisson distribution. We set the release probability in response to an action potential at the individual terminal levels to 6% (Dreyer et al., 2010), and if a release occurred, the DA concentration of the voxel was elevated by the equivalent of 3000 DA molecules as per Equation 1. The volume of each voxel was corrected for an extracellular volume fraction of 0.21 (Rice and Nicholson, 1991).

We did not incorporate paired-pulse depression in our model as most in vivo FSCV studies have not reported this phenomenon (Chergui et al., 1994; Garris and Wightman, 1994; Hamid et al., 2016; May and Wightman, 1989). In addition, we could explain the gradual blunt of the response during prolonged stimulation (Figure 2E) as the result of an equilibrium between release and uptake rather than a depression in release. Newer in vivo biosensor-based studies observe the same ‘blunting’ phenomenon during stimulation trains (Mohebi et al., 2023). A low initial release probability that scales well with frequency has also been reported for VMAT2-positive release sites in dopaminergic cultures where the axons are not severed from their cell bodies as in acute striatal slices (Silm et al., 2019). Note that we did not explicitly model autoreceptor inhibition at pacemaker activity. However, this value should be implicitly reflected in the in vivo estimates we base our model on.

When simulating bursts or trains of stimulations, action potentials were added as described for each simulation, but release probability was kept the same unless otherwise noted. Uptake was evenly distributed throughout the simulation space with a Vmax at 6 µm s–1 for DS and 2 µm s–1 for VS (see Appendix 2—table 2) and a Km at 210 nM (Hovde et al., 2019) and calculated for each voxel as per Equation 2. For each time step, dt, diffusion is calculated with a finite difference implementation of the Laplacian operator described in Equation 3 using a diffusion coefficient corrected for tortuosity at 321.7 µm2 s–1. Periodic boundaries were used to avoid edge issues with a simulation size of 50 x 50 × 50 µm unless otherwise noted. The Python-based implementation of the model can be found as described in the Code and Data Availability section.

Receptor occupancy

Our modelling of receptor binding was based on the work of Dreyer and Hounsgaard, 2013. Occupancy of the receptors for any given voxel was calculated numerically by numerical integration of:

dDxRocc,tdt=[DA]tkon(1DxRocc,t)koffDxRocc,t (6)

Where [DA]t was the dopamine concentration at the given voxel, DxRocc,t the fraction of DA receptors occupied in the same voxel, kon the rate constant and koff the reverse rate constant. The model assumed no buffering effect from DA bound to receptors, as DA receptors are GPCRs typically expressed at very low levels (Zhang et al., 2024).

Immunohistochemistry analysis

Analysed widefield images were obtained from Sørensen et al., 2021. The mouse striatum slices were stained for either DAT or VMAT2 see Sørensen et al., 2021 for slicing, fixation, staining, and imaging protocol (Sørensen et al., 2021). Fluorescence intensities were extracted in a single dorsoventral line parallel to the midline through the horizontally centre of the anterior commissure using ImageJ v1.53q for each slice. Data was vertically centred around the anterior commissure. No background subtraction was performed.

FSCV modelling

FSCV recordings were modelled by convolving a simulated DA response to a pseudo FSCV trace. The impulse function used was as described in Venton et al., 2002. In brief, the impulse function was defined as IFFSCV=e(t+1)(k1ts+k2to), where t is time, ts is scan time, to is oxidation time, and k1 and k2 desorption constants. ts was set to 100 ms as reported in May and Wightman, 1989 and to to 4 ms, which is half of the typically reported symmetrical waveform length. The desorption constants (k-1=1.2 s–1 and k-2=12 s–1) were taken directly from Venton et al., 2002.

Nanocluster uptake modelling

Nanoclustering of DAT was simulated in Python. An ellipsoid-shaped varicosity of 1.5 μm in length and 800 nm in width was modelled as a flat, square surface with a width of 1.8 μm to match the total surface area (Lycas et al., 2022; Rahbek-Clemmensen et al., 2017). As 9–16.4% of terminals in the striatum are estimated to be dopaminergic (Hökfelt, 1968; Tennyson et al., 1974), we set the height of the simulation space to 3.52 μm to generate an extracellular volume seven times the size of the varicosity. Axons and cell bodies are likely a non-negligible part of the striatal volume but omitted in this analysis due to a lack of information in the literature (however, decreasing the share of striatal space taken up by DA varicosities works in the direction of our hypothesis). Spatial granularity was set to 20 nm, and we randomly placed eight non-overlapping locations for clusters on the simulated varicosity. Uptake capacity per voxel for each clustering scenario was set so the mean uptake of the entire space was 4 μm s–1, which resulted in clusters with increased DAT density with decreasing cluster size.

For the steady state simulations, we added [DA] at a constant rate of 224 nM s–1 calculated as follows:

[DA]add=QconcfrateR%ATdensity (7)

Where DAadd was the DA concentration added per second, Qconc the DA concentration added to a voxel by a single release event, frate the firing rate at pacemaker activity, R% the probability of release for each action potential and ATdensity the density of actively releasing terminals. Qconc was calculated as follows:

Qconc=VesiclevolVoxelvolVesicleconc1EVF (8)

where Vesiclevol is the volume of a vesicle (with an assumed radius of 25 nm), Voxelvol the volume of a voxel in the simulation space, Vesicleconc the concentration of DA in a single vesicle (assuming 3000 DA molecules) and EVF the extracellular volume fraction of the striatum.

For the clearance after burst simulations, we set the initial DA concentration of the entire space to 100 nM.

We ran all the nanoclustering simulations with a time step of 1.875e–7 s to avoid numerical instability. Diffusion corrected for tortuosity was set to 321.7 µm2 s–1 and calculated with a Laplacian operation as described in Equation 3. Periodic boundaries were used to account for the varicosity being circular and avoid issues at the edge of the simulation space. The full implementation in Python can be found as described in the Code and Data Availability section.

Super-resolution clustering analysis

Super-resolved fluorescence microscopy dual-color images from Sørensen et al., 2021 of striatal brain slices from mice were analysed based on their position in the dorsal or ventral regions (Figure 4J). Localisations were fitted using DAOSTORM (Babcock et al., 2012) on the originally acquired direct stochastic optical reconstruction microscopy (dSTORM) videos with the following settings: background sigma of 8, maximum likelihood estimation as the fitting error model, 20 peak identification iterations, an initial sigma estimate of 1.5 and a threshold adjusted to each imaging session. Each image was analysed for percentage of localisations within a cluster using density-based spatial clustering of applications with noise (DBSCAN; Ester et al., 1996) using the Python package Scikit-learn 0.22 (Pedregosa et al., 2021). To uncover broader trends, we scanned across a range of parameters: radius was run from 10 nm to 200 nm and number of localisations from 10 to 200. For Figure 4M, a diameter of 80 nm was chosen to match the size reported in Rahbek-Clemmensen et al., 2017.

Statistical analysis

The statistical analyses performed can be found in the legends of each figure. Statistical analyses were performed using open-source python packages SciPy v1.5.2 and NumPy v1.18.1. Boxplots show the 25th and 75th percentile range, and whiskers indicate up to 1.5 times the interquartile range. The remaining data points are plotted as individual outliers.

Acknowledgements

We thank Dr. Kenneth L Madsen, University of Copenhagen for general input on our modelling and Dr. Nicolas Tritsch, New York University Grossman School of Medicine, for a fruitful discussion on the postsynaptic receptor properties and occupation.

Appendix 1

Supplementary text

Burst release and FSCV modelling

To test the validity of our model, we examined how it would respond to a simulated direct electrical stimulation. We chose this experimental paradigm, as direct stimulation of striatal slices with fast-scan cyclic voltammetry (FSCV) recordings of DA is the most common procedure in the literature to measure DA release. However, only around 10% of the DA release in such a procedure stems from direct stimulation of DA terminals, as 90% can be attributed to cholinergic release from interneurons activating presynaptic nicotinic receptors on the pre-synapse of dopaminergic axons (Liu et al., 2022; Liu et al., 2018; Zhou et al., 2001). This leads to a much stronger response than an action potential travelling up from the midbrain would generate, which is estimated to have an in vivo release probability on the order of 6% (Dreyer et al., 2010). We therefore simulated an event with 10 x release probability (60%) to scale to the expected output from an electrical stimulation in slices. The numbers for quantal size vary throughout the literature, but for consistency with previous simulations, we set the value to 3000 DA molecules (Cragg and Rice, 2004; Omiatek et al., 2010; Pothos et al., 1998; Sulzer and Pothos, 2000). On the uptake side, DAT has a Vmax in DS of roughly 6 μM s–1 and a Km of 210 nM (Appendix 2—table 2; Calipari et al., 2012; Dreyer et al., 2010; Hovde et al., 2019; May and Wightman, 1989; Salinas et al., 2023; Siciliano et al., 2014). In response to such a stimulation, mean DA concentration ([DA]) at an artificial carbon probe immediately rose to 200 nM with full return to baseline in roughly 0.2 s (Extended Data Figure 1B and C). This is significantly faster dynamics than what is typically observed using FSCV, but similar to newer observations made in the DS measured with the dLight biosensors (Atcherley et al., 2015; Brimblecombe et al., 2019; Mohebi et al., 2024; Salinas et al., 2023; Stuber et al., 2010; Xie et al., 2020). The discrepancy between our simulations and biosensor-based recordings versus those recording with FSCV measurements is likely a combination of adsorption rates and the holding period between scans in voltammetry (Burrell et al., 2015; Venton et al., 2002). To account for this, we inverted the deconvolution processes used in the literature to correct for DA kinetics observed with either voltammetry or amperometry (Extended Data Figure 1C; Atcherley et al., 2015; Gonon et al., 2000; Venton et al., 2002). After this process, our results were very similar to those typically observed with FSCV (Fig. S1B; Atcherley et al., 2015; Brimblecombe et al., 2019; Stuber et al., 2010; Xie et al., 2020).

Appendix 2

Tables 1 and 2

Appendix 2—table 1. Overview of reports on dopaminergic density and release in the striatum.

Only studies that assessed both regions in rodents are included. Studies that stimulate directly in the striatum are omitted due to the large activation of nicotinic receptors on DA terminals (1, 2). A.U.=arbitrary units, DS = dorsal striatum, VS=ventral striatum, TH = tyrosine hydroxylase.

Measure Ratio DS VS Units Species Source
TH expression density 100 % ~90 ~90 A.U. Mouse Alberquilla et al., 2020
TH immunoreactivity 95 % ~68 ~64 A.U. Mouse Kuroda et al., 2010
TH protein content 150 % 0.07 0.11 ng TH/µg prot. Mouse Salvatore et al., 2016
DA content 90 % ~155 ~140 ng DA/mg prot. Mouse Salvatore et al., 2016
TH immunoreactivity 75 % 2.8 2.1 A.U. Rat Huang et al., 2019
TH protein content 66 % 0.36 0.24 ng TH/µg prot. Mouse Salvatore et al., 2005
FSCV - [DA]p 91 % 57 52 nM Rat May and Wightman, 1989
FSCV - [DA]p 76 % 89.3 67.5 nM Rat Garris and Wightman, 1994
Median 90 % - - - - -

Appendix 2—table 2. Overview of reported Vmax values for DA uptake in the striatum.

Only studies that assessed both regions in rodents are included. DS = dorsal striatum, VS=ventral striatum, FSCV = fast scan cyclic voltammetry.

Method VS/DS Ratio DS (uM/s) VS (uM/s) Species Source
FSCV 29 % 7.0 2.0 Mouse Calipari et al., 2012
FSCV 28 % 6.0 1.7 Rat Calipari et al., 2012
FSCV 47 % 3.0 1.4 Rat May and Wightman, 1989
FSCV 31 % 6.5 2.0 Mouse Siciliano et al., 2014
FSCV 44 % 5.0 2.2 Rat Ferris et al., 2014
Median 31 % 6.0 2.0 - -

Funding Statement

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Contributor Information

Freja Herborg, Email: frejahh@sund.ku.dk.

Ulrik Gether, Email: gether@sund.ku.dk.

Roshan Cools, Donders Institute for Brain, Cognition and Behaviour, Radboud University Nijmegen, Netherlands.

Michael J Frank, Brown University, United States.

Funding Information

This paper was supported by the following grants:

  • Lundbeck Foundation R266-2017-4331 to Ulrik Gether.

  • Lundbeck Foundation R276-2018-792 to Ulrik Gether.

  • Lundbeck Foundation R359-2020-2301 to Ulrik Gether.

  • Lundbeck Foundation R181-2014-3090 to Freja Herborg.

  • Lundbeck Foundation R303-2018-3540 to Freja Herborg.

  • The Novo Nordisk Foundation NNF24OC0088870 to Freja Herborg.

Additional information

Competing interests

No competing interests declared.

is affiliated with H. Lundbeck A/S. The author has no other competing interests to declare.

Author contributions

Conceptualization, Data curation, Software, Formal analysis, Validation, Visualization, Methodology, Writing – original draft, Writing – review and editing.

Software, Methodology, Writing – review and editing.

Investigation, Methodology, Writing – review and editing.

Investigation, Methodology, Writing – review and editing.

Conceptualization, Writing – review and editing.

Conceptualization, Writing – review and editing.

Conceptualization, Formal analysis, Supervision, Funding acquisition, Writing – original draft, Project administration, Writing – review and editing.

Conceptualization, Formal analysis, Supervision, Funding acquisition, Writing – original draft, Project administration, Writing – review and editing.

Additional files

MDAR checklist

Data availability

Numerical implementation and code to run the simulations in a Jupyter notebook format are available at: https://github.com/GetherLab/striatal-dopamine-modelling (copy archived at Ejdrup, 2024) or in the source code files accompanying the article in .Py format. The data for Figure 4 can be simulated with the provided source code (Figure 4—source code 1) or found at https://doi.org/10.5281/zenodo.18046987 alongside the data for Figure 2—figure supplement 1. The localization files for all dSTORM image analyzed in the paper can also be found at https://doi.org/10.5281/zenodo.18046987. These .txt files contain all the necessary data for the analyses conducted and can be used in combination with the drift correction files also uploaded to recreate the images.

The following dataset was generated:

Aske E. 2025. Data for the paper "Computational modelling identifies key determinants of subregion-specific dopamine dynamics in the striatum", Ejdrup et. al, 2025. Zenodo.

References

  1. Agnati LF, Bjelke B, Fuxe K. Volume versus wiring transmission in the brain: A new theoretical frame for neuropsychopharmacology. Medicinal Research Reviews. 1995;15:33–45. doi: 10.1002/med.2610150104. [DOI] [PubMed] [Google Scholar]
  2. Ågren R, Stepniewski TM, Zeberg H, Selent J, Sahlholm K. Dopamine D2 receptor agonist binding kinetics-role of a conserved serine residue. International Journal of Molecular Sciences. 2021;22:4078. doi: 10.3390/ijms22084078. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Alberquilla S, Gonzalez-Granillo A, Martin ED, Moratalla R. Dopamine regulates spine density in striatal projection neurons in a concentration-dependent manner. Neurobiology of Disease. 2020;134:104666. doi: 10.1016/j.nbd.2019.104666. [DOI] [PubMed] [Google Scholar]
  4. Arbuthnott GW, Wickens J. Space, time and dopamine. Trends in Neurosciences. 2007;30:62–69. doi: 10.1016/j.tins.2006.12.003. [DOI] [PubMed] [Google Scholar]
  5. Atcherley CW, Laude ND, Monroe EB, Wood KM, Hashemi P, Heien ML. Improved calibration of voltammetric sensors for studying pharmacological effects on dopamine transporter kinetics in vivo. ACS Chemical Neuroscience. 2015;6:1509–1516. doi: 10.1021/cn500020s. [DOI] [PubMed] [Google Scholar]
  6. Babcock H, Sigal YM, Zhuang X. A high-density 3D localization algorithm for stochastic optical reconstruction microscopy. Optical Nanoscopy. 2012;1:110. doi: 10.1186/2192-2853-1-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Berke JD. What does dopamine mean? Nature Neuroscience. 2018;21:787–793. doi: 10.1038/s41593-018-0152-y. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Beyene AG, McFarlane IR, Pinals RL, Landry MP. Stochastic simulation of dopamine neuromodulation for implementation of fluorescent neurochemical probes in the striatal extracellular space. ACS Chemical Neuroscience. 2017;8:2275–2289. doi: 10.1021/acschemneuro.7b00193. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Block ER, Nuttle J, Balcita-Pedicino JJ, Caltagarone J, Watkins SC, Sesack SR, Sorkin A. Brain region-specific trafficking of the dopamine transporter. The Journal of Neuroscience. 2015;35:12845–12858. doi: 10.1523/JNEUROSCI.1391-15.2015. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Borroto-Escuela DO, Perez De La Mora M, Manger P, Narváez M, Beggiato S, Crespo-Ramírez M, Navarro G, Wydra K, Díaz-Cabiale Z, Rivera A, Ferraro L, Tanganelli S, Filip M, Franco R, Fuxe K. Brain dopamine transmission in health and Parkinson’s disease: Modulation of synaptic transmission and plasticity through volume transmission and dopamine heteroreceptors. Frontiers in Synaptic Neuroscience. 2018;10:20. doi: 10.3389/fnsyn.2018.00020. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Brimblecombe KR, Vietti-Michelina S, Platt NJ, Kastli R, Hnieno A, Gracie CJ, Cragg SJ. Calbindin-D28K limits dopamine release in ventral but not dorsal striatum by regulating Ca2+ availability and dopamine transporter function. ACS Chemical Neuroscience. 2019;10:3419–3426. doi: 10.1021/acschemneuro.9b00325. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Brown HD, McCutcheon JE, Cone JJ, Ragozzino ME, Roitman MF. Primary food reward and reward-predictive stimuli evoke different patterns of phasic dopamine signaling throughout the striatum. The European Journal of Neuroscience. 2011;34:1997–2006. doi: 10.1111/j.1460-9568.2011.07914.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Burrell MH, Atcherley CW, Heien ML, Lipski J. A novel electrochemical approach for prolonged measurement of absolute levels of extracellular dopamine in brain slices. ACS Chemical Neuroscience. 2015;6:1802–1812. doi: 10.1021/acschemneuro.5b00120. [DOI] [PubMed] [Google Scholar]
  14. Burt DR, Creese I, Snyder SH. Properties of [3H]haloperidol and [3H]dopamine binding associated with dopamine receptors in calf brain membranes. Molecular Pharmacology. 1976;12:800–812. [PubMed] [Google Scholar]
  15. Calipari ES, Huggins KN, Mathews TA, Jones SR. Conserved dorsal-ventral gradient of dopamine release and uptake rate in mice, rats and rhesus macaques. Neurochemistry International. 2012;61:986–991. doi: 10.1016/j.neuint.2012.07.008. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Carboni E, Spielewoy C, Vacca C, Nosten-Bertrand M, Giros B, Di Chiara G. Cocaine and amphetamine increase extracellular dopamine in the nucleus accumbens of mice lacking the dopamine transporter gene. The Journal of Neuroscience. 2001;21:RC141. doi: 10.1523/JNEUROSCI.21-09-j0001.2001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Cardozo DL, Bean BP. Voltage-dependent calcium channels in rat midbrain dopamine neurons: modulation by dopamine and GABAB receptors. Journal of Neurophysiology. 1995;74:1137–1148. doi: 10.1152/jn.1995.74.3.1137. [DOI] [PubMed] [Google Scholar]
  18. Carvelli L, Morón JA, Kahlig KM, Ferrer JV, Sen N, Lechleiter JD, Leeb-Lundberg LMF, Merrill G, Lafer EM, Ballou LM, Shippenberg TS, Javitch JA, Lin RZ, Galli A. PI 3-kinase regulation of dopamine uptake. Journal of Neurochemistry. 2002;81:859–869. doi: 10.1046/j.1471-4159.2002.00892.x. [DOI] [PubMed] [Google Scholar]
  19. Chefer VI, Thompson AC, Zapata A, Shippenberg TS. Overview of Brain Microdialysis. Current Protocols in Neuroscience. 2009;chapter 7:Unit7.1. doi: 10.1002/0471142301.ns0701s47. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Chergui K, Suaud-Chagny MF, Gonon F. Nonlinear relationship between impulse flow, dopamine release and dopamine elimination in the rat brain in vivo. Neuroscience. 1994;62:641–645. doi: 10.1016/0306-4522(94)90465-0. [DOI] [PubMed] [Google Scholar]
  21. Cragg SJ, Rice ME. DAncing past the DAT at a DA synapse. Trends in Neurosciences. 2004;27:270–277. doi: 10.1016/j.tins.2004.03.011. [DOI] [PubMed] [Google Scholar]
  22. Dodson PD, Dreyer JK, Jennings KA, Syed ECJ, Wade-Martins R, Cragg SJ, Bolam JP, Magill PJ. Representation of spontaneous movement by dopaminergic neurons is cell-type selective and disrupted in parkinsonism. PNAS. 2016;113:E2180–E2188. doi: 10.1073/pnas.1515941113. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Doucet G, Descarries L, Garcia S. Quantification of the dopamine innervation in adult rat neostriatum. Neuroscience. 1986;19:427–445. doi: 10.1016/0306-4522(86)90272-1. [DOI] [PubMed] [Google Scholar]
  24. Dreyer JK, Herrik KF, Berg RW, Hounsgaard JD. Influence of phasic and tonic dopamine release on receptor activation. The Journal of Neuroscience. 2010;30:14273–14283. doi: 10.1523/JNEUROSCI.1894-10.2010. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Dreyer JK, Hounsgaard J. Mathematical model of dopamine autoreceptors and uptake inhibitors and their influence on tonic and phasic dopamine signaling. Journal of Neurophysiology. 2013;109:171–182. doi: 10.1152/jn.00502.2012. [DOI] [PubMed] [Google Scholar]
  26. Dreyer JK, Vander Weele CM, Lovic V, Aragona BJ. Functionally distinct dopamine signals in nucleus accumbens core and shell in the freely moving rat. The Journal of Neuroscience. 2016;36:98–112. doi: 10.1523/JNEUROSCI.2326-15.2016. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Ducrot C, Bourque M-J, Delmas CVL, Racine A-S, Guadarrama Bello D, Delignat-Lavaud B, Domenic Lycas M, Fallon A, Michaud-Tardif C, Burke Nanni S, Herborg F, Gether U, Nanci A, Takahashi H, Parent M, Trudeau L-E. Dopaminergic neurons establish a distinctive axonal arbor with a majority of non-synaptic terminals. FASEB Journal. 2021;35:e21791. doi: 10.1096/fj.202100201RR. [DOI] [PubMed] [Google Scholar]
  28. Ejdrup AL, Wellbourne-Wood J, Dreyer JK, Guldhammer N, Lycas MD, Gether U, Hall BJ, Sørensen G. Within-mice comparison of microdialysis and fiber photometry-recorded dopamine biosensor during amphetamine response. ACS Chemical Neuroscience. 2023;14:1622–1630. doi: 10.1021/acschemneuro.2c00817. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Ejdrup AL. Striatal-dopamine-modelling. swh:1:rev:0417fb0c6ab5f91a1515f1be40693a54e3fa9e02Software Heritage. 2024 https://archive.softwareheritage.org/swh:1:dir:8489e680447d60bcf3ae268fec81abbf238996cb;origin=https://github.com/GetherLab/striatal-dopamine-modelling;visit=swh:1:snp:91cd83d0a02424cfbd615a912192df12bae3f27a;anchor=swh:1:rev:0417fb0c6ab5f91a1515f1be40693a54e3fa9e02
  30. Eriksen J, Rasmussen SGF, Rasmussen TN, Vaegter CB, Cha JH, Zou M-F, Newman AH, Gether U. Visualization of dopamine transporter trafficking in live neurons by use of fluorescent cocaine analogs. The Journal of Neuroscience. 2009;29:6794–6808. doi: 10.1523/JNEUROSCI.4177-08.2009. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Eriksen J, Jørgensen TN, Gether U. Regulation of dopamine transporter function by protein-protein interactions: new discoveries and methodological challenges. Journal of Neurochemistry. 2010;113:27–41. doi: 10.1111/j.1471-4159.2010.06599.x. [DOI] [PubMed] [Google Scholar]
  32. Ester M, Kriegel HP, Sander J, Xu X. A density-based algorithm for discovering clusters in large spatial databases with noise. Proceedings of the Second International Conference on Knowledge Discovery and Data Mining; 1996. pp. 226–231. [Google Scholar]
  33. Fagan RR, Kearney PJ, Sweeney CG, Luethi D, Schoot Uiterkamp FE, Schicker K, Alejandro BS, O’Connor LC, Sitte HH, Melikian HE. Dopamine transporter trafficking and Rit2 GTPase: Mechanism of action and in vivo impact. The Journal of Biological Chemistry. 2020;295:5229–5244. doi: 10.1074/jbc.RA120.012628. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Farrell K, Lak A, Saleem AB. Midbrain dopamine neurons signal phasic and ramping reward prediction error during goal-directed navigation. Cell Reports. 2022;41:111470. doi: 10.1016/j.celrep.2022.111470. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Ferris MJ, España RA, Locke JL, Konstantopoulos JK, Rose JH, Chen R, Jones SR. Dopamine transporters govern diurnal variation in extracellular dopamine tone. PNAS. 2014;111:E2751–E2759. doi: 10.1073/pnas.1407935111. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Garris PA, Ciolkowski EL, Pastore P, Wightman RM. Efflux of dopamine from the synaptic cleft in the nucleus accumbens of the rat brain. The Journal of Neuroscience. 1994;14:6084–6093. doi: 10.1523/JNEUROSCI.14-10-06084.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Garris PA, Wightman RM. Different kinetics govern dopaminergic transmission in the amygdala, prefrontal cortex, and striatum: An in vivo voltammetric study. The Journal of Neuroscience. 1994;14:442–450. doi: 10.1523/JNEUROSCI.14-01-00442.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Gonon F, Burie JB, Jaber M, Benoit-Marand M, Dumartin B, Bloch B. Geometry and kinetics of dopaminergic transmission in the rat striatum and in mice lacking the dopamine transporter. Progress in Brain Research. 2000;125:291–302. doi: 10.1016/S0079-6123(00)25018-8. [DOI] [PubMed] [Google Scholar]
  39. Grace AA, Floresco SB, Goto Y, Lodge DJ. Regulation of firing of dopaminergic neurons and control of goal-directed behaviors. Trends in Neurosciences. 2007;30:220–227. doi: 10.1016/j.tins.2007.03.003. [DOI] [PubMed] [Google Scholar]
  40. Greenstreet F, Vergara HM, Johansson Y, Pati S, Schwarz L, Lenzi SC, Geerts JP, Wisdom M, Gubanova A, Rollik LB, Kaur J, Moskovitz T, Cohen J, Thompson E, Margrie TW, Clopath C, Stephenson-Jones M. Dopaminergic action prediction errors serve as a value-free teaching signal. Nature. 2025;643:1333–1342. doi: 10.1038/s41586-025-09008-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Hamid AA, Pettibone JR, Mabrouk OS, Hetrick VL, Schmidt R, Vander Weele CM, Kennedy RT, Aragona BJ, Berke JD. Mesolimbic dopamine signals the value of work. Nature Neuroscience. 2016;19:117–126. doi: 10.1038/nn.4173. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Hamid AA, Frank MJ, Moore CI. Wave-like dopamine dynamics as a mechanism for spatiotemporal credit assignment. Cell. 2021;184:2733–2749. doi: 10.1016/j.cell.2021.03.046. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Hökfelt T. In vitro studies on central and peripheral monoamine neurons at the ultrastructural level. Zeitschrift Fur Zellforschung Und Mikroskopische Anatomie. 1968;91:1–74. doi: 10.1007/BF00336984. [DOI] [PubMed] [Google Scholar]
  44. Hovde MJ, Larson GH, Vaughan RA, Foster JD. Model systems for analysis of dopamine transporter function and regulation. Neurochemistry International. 2019;123:13–21. doi: 10.1016/j.neuint.2018.08.015. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Howe MW, Tierney PL, Sandberg SG, Phillips PEM, Graybiel AM. Prolonged dopamine signalling in striatum signals proximity and value of distant rewards. Nature. 2013;500:575–579. doi: 10.1038/nature12475. [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Howe MW, Dombeck DA. Rapid signalling in distinct dopaminergic axons during locomotion and reward. Nature. 2016;535:505–510. doi: 10.1038/nature18942. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Huang WS, Chen GJ, Tsai TH, Cheng CY, Shiue CY, Ma KH, Yeh SHH. In vivo long-lasting alterations of central serotonin transporter activity and associated dopamine synthesis after acute repeated administration of methamphetamine. EJNMMI Research. 2019;9:92. doi: 10.1186/s13550-019-0557-y. [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. Hunger L, Kumar A, Schmidt R. Abundance compensates kinetics: Similar effect of dopamine signals on D1 and D2 receptor populations. The Journal of Neuroscience. 2020;40:2868–2881. doi: 10.1523/JNEUROSCI.1951-19.2019. [DOI] [PMC free article] [PubMed] [Google Scholar]
  49. Jones SR, Gainetdinov RR, Jaber M, Giros B, Wightman RM, Caron MG. Profound neuronal plasticity in response to inactivation of the dopamine transporter. PNAS. 1998;95:4029–4034. doi: 10.1073/pnas.95.7.4029. [DOI] [PMC free article] [PubMed] [Google Scholar]
  50. Jørgensen SH, Ejdrup AL, Lycas MD, Posselt LP, Madsen KL, Tian L, Dreyer JK, Herborg F, Sørensen AT, Gether U. Behavioral encoding across timescales by region-specific dopamine dynamics. PNAS. 2023;120:e2215230120. doi: 10.1073/pnas.2215230120. [DOI] [PMC free article] [PubMed] [Google Scholar]
  51. Kearney PJ, Bolden NC, Kahuno E, Conklin TL, Martin GE, Lubec G, Melikian HE. Presynaptic Gq-coupled receptors drive biphasic dopamine transporter trafficking that modulates dopamine clearance and motor function. The Journal of Biological Chemistry. 2023;299:102900. doi: 10.1016/j.jbc.2023.102900. [DOI] [PMC free article] [PubMed] [Google Scholar]
  52. Klaus A, Alves da Silva J, Costa RM. What, if, and when to move: basal ganglia circuits and self-paced action initiation. Annual Review of Neuroscience. 2019;42:459–483. doi: 10.1146/annurev-neuro-072116-031033. [DOI] [PubMed] [Google Scholar]
  53. Kristensen AS, Andersen J, Jørgensen TN, Sørensen L, Eriksen J, Loland CJ, Strømgaard K, Gether U. SLC6 neurotransmitter transporters: Structure, function, and regulation. Pharmacological Reviews. 2011;63:585–640. doi: 10.1124/pr.108.000869. [DOI] [PubMed] [Google Scholar]
  54. Kuczenski R, Segal DS. Differential effects of amphetamine and dopamine uptake blockers (cocaine, nomifensine) on caudate and accumbens dialysate dopamine and 3-methoxytyramine. The Journal of Pharmacology and Experimental Therapeutics. 1992;262:1085–1094. [PubMed] [Google Scholar]
  55. Kuroda KO, Ornthanalai VG, Kato T, Murphy NP. FosB null mutant mice show enhanced methamphetamine neurotoxicity: potential involvement of FosB in intracellular feedback signaling and astroglial function. Neuropsychopharmacology. 2010;35:641–655. doi: 10.1038/npp.2009.169. [DOI] [PMC free article] [PubMed] [Google Scholar]
  56. Labouesse MA, Patriarchi T. A versatile GPCR toolkit to track in vivo neuromodulation: not a one-size-fits-all sensor. Neuropsychopharmacology. 2021;46:2043–2047. doi: 10.1038/s41386-021-00982-y. [DOI] [PMC free article] [PubMed] [Google Scholar]
  57. Lee SJ, Lodder B, Chen Y, Patriarchi T, Tian L, Sabatini BL. Cell-type specific asynchronous modulation of PKA by dopamine during reward based learning. bioRxiv. 2020 doi: 10.1101/839035. [DOI] [PMC free article] [PubMed]
  58. Liu C, Kershberg L, Wang J, Schneeberger S, Kaeser PS. Dopamine secretion is mediated by sparse active zone-like release sites. Cell. 2018;172:706–718. doi: 10.1016/j.cell.2018.01.008. [DOI] [PMC free article] [PubMed] [Google Scholar]
  59. Liu C, Goel P, Kaeser PS. Spatial and temporal scales of dopamine transmission. Nature Reviews Neuroscience. 2021;22:345–358. doi: 10.1038/s41583-021-00455-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  60. Liu C, Cai X, Ritzau-Jost A, Kramer PF, Li Y, Khaliq ZM, Hallermann S, Kaeser PS. An action potential initiation mechanism in distal axons for the control of dopamine release. Science. 2022;375:1378–1385. doi: 10.1126/science.abn0532. [DOI] [PMC free article] [PubMed] [Google Scholar]
  61. Lycas MD, Ejdrup AL, Sørensen AT, Haahr NO, Jørgensen SH, Guthrie DA, Støier JF, Werner C, Newman AH, Sauer M, Herborg F, Gether U. Nanoscopic dopamine transporter distribution and conformation are inversely regulated by excitatory drive and D2 autoreceptor activity. Cell Reports. 2022;40:111431. doi: 10.1016/j.celrep.2022.111431. [DOI] [PMC free article] [PubMed] [Google Scholar]
  62. Maeno H. Dopamine receptors in canine caudate nucleus. Molecular and Cellular Biochemistry. 1982;43:65–80. doi: 10.1007/BF00423094. [DOI] [PubMed] [Google Scholar]
  63. Maisonneuve IM, Glick SD. Interactions between ibogaine and cocaine in rats: In vivo microdialysis and motor behavior. European Journal of Pharmacology. 1992;212:263–266. doi: 10.1016/0014-2999(92)90340-a. [DOI] [PubMed] [Google Scholar]
  64. Markowitz JE, Gillis WF, Jay M, Wood J, Harris RW, Cieszkowski R, Scott R, Brann D, Koveal D, Kula T, Weinreb C, Osman MAM, Pinto SR, Uchida N, Linderman SW, Sabatini BL, Datta SR. Spontaneous behaviour is structured by reinforcement without explicit reward. Nature. 2023;614:108–117. doi: 10.1038/s41586-022-05611-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  65. Matityahu L, Gilin N, Sarpong GA, Atamna Y, Tiroshi L, Tritsch NX, Wickens JR, Goldberg JA. Acetylcholine waves and dopamine release in the striatum. Nature Communications. 2023;14:6852. doi: 10.1038/s41467-023-42311-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  66. Matsuda W, Furuta T, Nakamura KC, Hioki H, Fujiyama F, Arai R, Kaneko T. Single nigrostriatal dopaminergic neurons form widely spread and highly dense axonal arborizations in the neostriatum. The Journal of Neuroscience. 2009;29:444–453. doi: 10.1523/JNEUROSCI.4029-08.2009. [DOI] [PMC free article] [PubMed] [Google Scholar]
  67. May LJ, Wightman RM. Effects of D-2 antagonists on frequency-dependent stimulated dopamine overflow in nucleus accumbens and caudate-putamen. Journal of Neurochemistry. 1989;53:898–906. doi: 10.1111/j.1471-4159.1989.tb11789.x. [DOI] [PubMed] [Google Scholar]
  68. Mohebi A, Collins VL, Berke JD. Accumbens cholinergic interneurons dynamically promote dopamine release and enable motivation. eLife. 2023;12:e85011. doi: 10.7554/eLife.85011. [DOI] [PMC free article] [PubMed] [Google Scholar]
  69. Mohebi A, Wei W, Pelattini L, Kim K, Berke JD. Dopamine transients follow a striatal gradient of reward time horizons. Nature Neuroscience. 2024;27:737–746. doi: 10.1038/s41593-023-01566-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
  70. Nicholson C, Phillips JM. Ion diffusion modified by tortuosity and volume fraction in the extracellular microenvironment of the rat cerebellum. J Physiol. 1981;321:225–257. doi: 10.1113/jphysiol.1981.sp013981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  71. Nicholson C. Diffusion from an injected volume of a substance in brain tissue with arbitrary volume fraction and tortuosity. Brain Research. 1985;333:325–329. doi: 10.1016/0006-8993(85)91586-0. [DOI] [PubMed] [Google Scholar]
  72. Nicholson C. Interaction between diffusion and Michaelis-Menten uptake of dopamine after iontophoresis in striatum. Biophysical Journal. 1995;68:1699–1715. doi: 10.1016/S0006-3495(95)80348-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  73. Nishikori K, Noshiro O, Sano K, Maeno H. Characterization, solubilization, and separation of two distinct dopamine receptors in canine caudate nucleus. Journal of Biological Chemistry. 1980;255:10909–10915. doi: 10.1016/S0021-9258(19)70393-7. [DOI] [PubMed] [Google Scholar]
  74. Niv Y, Daw ND, Joel D, Dayan P. Tonic dopamine: Opportunity costs and the control of response vigor. Psychopharmacology. 2007;191:507–520. doi: 10.1007/s00213-006-0502-4. [DOI] [PubMed] [Google Scholar]
  75. Olson L, Seiger Å, Fuxe K. Heterogeneity of striatal and limbic dopamine innervation: Highly fluorescent islands in developing and adult rats. Brain Research. 1972;44:283–288. doi: 10.1016/0006-8993(72)90385-X. [DOI] [PubMed] [Google Scholar]
  76. Omiatek DM, Dong Y, Heien ML, Ewing AG. Only a fraction of quantal content is released during exocytosis as revealed by electrochemical cytometry of secretory vesicles. ACS Chemical Neuroscience. 2010;1:234–245. doi: 10.1021/cn900040e. [DOI] [PMC free article] [PubMed] [Google Scholar]
  77. Paladini CA, Robinson S, Morikawa H, Williams JT, Palmiter RD. Dopamine controls the firing pattern of dopamine neurons via a network feedback mechanism. PNAS. 2003;100:2866–2871. doi: 10.1073/pnas.0138018100. [DOI] [PMC free article] [PubMed] [Google Scholar]
  78. Pedregosa F, Varoquaux G, Gramfort A, Michel V, Thirion B, Grisel O, Blondel M, Prettenhofer P, Weiss R, Dubourg V. Scikit-learn: machine learning in python. Journal of Machine Learning Research. 2021;12:2825–2830. [Google Scholar]
  79. Pereira DB, Schmitz Y, Mészáros J, Merchant P, Hu G, Li S, Henke A, Lizardi-Ortiz JE, Karpowicz RJ, Morgenstern TJ, Sonders MS, Kanter E, Rodriguez PC, Mosharov EV, Sames D, Sulzer D. Fluorescent false neurotransmitter reveals functionally silent dopamine vesicle clusters in the striatum. Nature Neuroscience. 2016;19:578–586. doi: 10.1038/nn.4252. [DOI] [PMC free article] [PubMed] [Google Scholar]
  80. Pothos EN, Davila V, Sulzer D. Presynaptic recording of quanta from midbrain dopamine neurons and modulation of the quantal size. The Journal of Neuroscience. 1998;18:4106–4118. doi: 10.1523/JNEUROSCI.18-11-04106.1998. [DOI] [PMC free article] [PubMed] [Google Scholar]
  81. Rahbek-Clemmensen T, Lycas MD, Erlendsson S, Eriksen J, Apuschkin M, Vilhardt F, Jørgensen TN, Hansen FH, Gether U. Super-resolution microscopy reveals functional organization of dopamine transporters into cholesterol and neuronal activity-dependent nanodomains. Nature Communications. 2017;8:740. doi: 10.1038/s41467-017-00790-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
  82. Rice ME, Nicholson C. Diffusion characteristics and extracellular volume fraction during normoxia and hypoxia in slices of rat neostriatum. Journal of Neurophysiology. 1991;65:264–272. doi: 10.1152/jn.1991.65.2.264. [DOI] [PubMed] [Google Scholar]
  83. Richards TL, Zahniser NR. Rapid substrate-induced down-regulation in function and surface localization of dopamine transporters: rat dorsal striatum versus nucleus accumbens. Journal of Neurochemistry. 2009;108:1575–1584. doi: 10.1111/j.1471-4159.2009.05910.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  84. Salinas AG, Lee JO, Augustin SM, Zhang S, Patriarchi T, Tian L, Morales M, Mateo Y, Lovinger DM. Distinct sub-second dopamine signaling in dorsolateral striatum measured by a genetically-encoded fluorescent sensor. Nature Communications. 2023;14:5915. doi: 10.1038/s41467-023-41581-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
  85. Salvatore MF, Fisher B, Surgener SP, Gerhardt GA, Rouault T. Neurochemical investigations of dopamine neuronal systems in iron-regulatory protein 2 (IRP-2) knockout mice. Brain Research. Molecular Brain Research. 2005;139:341–347. doi: 10.1016/j.molbrainres.2005.06.002. [DOI] [PubMed] [Google Scholar]
  86. Salvatore MF, Calipari ES, Jones SR. Regulation of tyrosine hydroxylase expression and phosphorylation in dopamine transporter-deficient mice. ACS Chemical Neuroscience. 2016;7:941–951. doi: 10.1021/acschemneuro.6b00064. [DOI] [PMC free article] [PubMed] [Google Scholar]
  87. Sano K, Noshiro O, Katsuda K, Nishikori K, Maeno H. Dopamine receptors and dopamine-sensitive adenylate cyclase in canine caudate nucleus: Characterization and solubilization. Biochemical Pharmacology. 1979;28:3617–3627. doi: 10.1016/0006-2952(79)90408-8. [DOI] [PubMed] [Google Scholar]
  88. Schultz W. Multiple dopamine functions at different time courses. Annual Review of Neuroscience. 2007;30:259–288. doi: 10.1146/annurev.neuro.28.061604.135722. [DOI] [PubMed] [Google Scholar]
  89. Shen H-W, Hagino Y, Kobayashi H, Shinohara-Tanaka K, Ikeda K, Yamamoto H, Yamamoto T, Lesch K-P, Murphy DL, Hall FS, Uhl GR, Sora I. Regional differences in extracellular dopamine and serotonin assessed by in vivo microdialysis in mice lacking dopamine and/or serotonin transporters. Neuropsychopharmacology. 2004;29:1790–1799. doi: 10.1038/sj.npp.1300476. [DOI] [PubMed] [Google Scholar]
  90. Siciliano CA, Calipari ES, Jones SR. Amphetamine potency varies with dopamine uptake rate across striatal subregions. Journal of Neurochemistry. 2014;131:348–355. doi: 10.1111/jnc.12808. [DOI] [PMC free article] [PubMed] [Google Scholar]
  91. Silm K, Yang J, Marcott PF, Asensio CS, Eriksen J, Guthrie DA, Newman AH, Ford CP, Edwards RH. Synaptic vesicle recycling pathway determines neurotransmitter content and release properties. Neuron. 2019;102:786–800. doi: 10.1016/j.neuron.2019.03.031. [DOI] [PMC free article] [PubMed] [Google Scholar]
  92. Sippy T, Tritsch NX. Unraveling the dynamics of dopamine release and its actions on target cells. Trends in Neurosciences. 2023;46:228–239. doi: 10.1016/j.tins.2022.12.005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  93. Sørensen G, Rickhag M, Leo D, Lycas MD, Ridderstrøm PH, Weikop P, Lilja JH, Rifes P, Herborg F, Woldbye D, Wörtwein G, Gainetdinov RR, Fink-Jensen A, Gether U. Disruption of the PDZ domain-binding motif of the dopamine transporter uniquely alters nanoscale distribution, dopamine homeostasis, and reward motivation. The Journal of Biological Chemistry. 2021;297:101361. doi: 10.1016/j.jbc.2021.101361. [DOI] [PMC free article] [PubMed] [Google Scholar]
  94. Staal RGW, Mosharov EV, Sulzer D. Dopamine neurons release transmitter via a flickering fusion pore. Nature Neuroscience. 2004;7:341–346. doi: 10.1038/nn1205. [DOI] [PubMed] [Google Scholar]
  95. Stuber GD, Hnasko TS, Britt JP, Edwards RH, Bonci A. Dopaminergic terminals in the nucleus accumbens but not the dorsal striatum corelease glutamate. The Journal of Neuroscience. 2010;30:8229–8233. doi: 10.1523/JNEUROSCI.1754-10.2010. [DOI] [PMC free article] [PubMed] [Google Scholar]
  96. Sulzer D, Pothos EN. Regulation of quantal size by presynaptic mechanisms. Reviews in the Neurosciences. 2000;11:159–212. doi: 10.1515/revneuro.2000.11.2-3.159. [DOI] [PubMed] [Google Scholar]
  97. Sulzer D, Cragg SJ, Rice ME. Striatal dopamine neurotransmission: regulation of release and uptake. Basal Ganglia. 2016;6:123–148. doi: 10.1016/j.baga.2016.02.001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  98. Tennyson VM, Heikkila R, Mytilineou C, Côté L, Cohen G. 5-Hydroxydopamine “tagged” neuronal boutons in rabbit neostriatum: interrelationship between vesicles and axonal membrane. Brain Research. 1974;82:341–348. doi: 10.1016/0006-8993(74)90617-9. [DOI] [PubMed] [Google Scholar]
  99. Threlfell S, Clements MA, Khodai T, Pienaar IS, Exley R, Wess J, Cragg SJ. Striatal muscarinic receptors promote activity dependence of dopamine transmission via distinct receptor subtypes on cholinergic interneurons in ventral versus dorsal striatum. The Journal of Neuroscience. 2010;30:3398–3408. doi: 10.1523/JNEUROSCI.5620-09.2010. [DOI] [PMC free article] [PubMed] [Google Scholar]
  100. Venton BJ, Troyer KP, Wightman RM. Response times of carbon fiber microelectrodes to dynamic changes in catecholamine concentration. Analytical Chemistry. 2002;74:539–546. doi: 10.1021/ac010819a. [DOI] [PubMed] [Google Scholar]
  101. Venton BJ, Zhang H, Garris PA, Phillips PEM, Sulzer D, Wightman RM. Real‐time decoding of dopamine concentration changes in the caudate–putamen during tonic and phasic firing. Journal of Neurochemistry. 2003;87:1284–1295. doi: 10.1046/j.1471-4159.2003.02109.x. [DOI] [PubMed] [Google Scholar]
  102. Wickens JR, Budd CS, Hyland BI, Arbuthnott GW. Striatal contributions to reward and decision making: making sense of regional variations in a reiterated processing matrix. Annals of the New York Academy of Sciences. 2007;1104:192–212. doi: 10.1196/annals.1390.016. [DOI] [PubMed] [Google Scholar]
  103. Wiencke K, Horstmann A, Mathar D, Villringer A, Neumann J. Dopamine release, diffusion and uptake: A computational model for synaptic and volume transmission. PLOS Computational Biology. 2020;16:e1008410. doi: 10.1371/journal.pcbi.1008410. [DOI] [PMC free article] [PubMed] [Google Scholar]
  104. Wu Q, Reith MEA, Kuhar MJ, Carroll FI, Garris PA. Preferential increases in nucleus accumbens dopamine after systemic cocaine administration are caused by unique characteristics of dopamine neurotransmission. The Journal of Neuroscience. 2001;21:6338–6347. doi: 10.1523/JNEUROSCI.21-16-06338.2001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  105. Xie K, Wang N, Lin X, Wang Z, Zhao X, Fang P, Yue H, Kim J, Luo J, Cui S, Yan F, Shi P. Organic electrochemical transistor arrays for real-time mapping of evoked neurotransmitter release in vivo. eLife. 2020;9:e50345. doi: 10.7554/eLife.50345. [DOI] [PMC free article] [PubMed] [Google Scholar]
  106. Zhang M, Chen T, Lu X, Lan X, Chen Z, Lu S. G protein-coupled receptors (GPCRs): advances in structures, mechanisms, and drug discovery. Signal Transduction and Targeted Therapy. 2024;9:88. doi: 10.1038/s41392-024-01803-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  107. Zhou FM, Liang Y, Dani JA. Endogenous nicotinic cholinergic activity regulates dopamine release in the striatum. Nature Neuroscience. 2001;4:1224–1229. doi: 10.1038/nn769. [DOI] [PubMed] [Google Scholar]
  108. Zhu S, Zhao C, Wu Y, Yang Q, Shao A, Wang T, Wu J, Yin Y, Li Y, Hou J, Zhang X, Zhou G, Gu X, Wang X, Bustelo XR, Zhou J. Identification of a Vav2-dependent mechanism for GDNF/Ret control of mesolimbic DAT trafficking. Nature Neuroscience. 2015;18:1084–1093. doi: 10.1038/nn.4060. [DOI] [PubMed] [Google Scholar]

eLife Assessment

Roshan Cools 1

The conclusions of this work are based on valuable simulations of a detailed model of striatal dopamine dynamics. Establishing that lower dopamine uptake rate can lead to a "tonic" level of dopamine in the ventral but not dorsal striatum, and that dopamine concentration changes at short delays can be tracked by D1 but not D2 receptor activation, is invaluable and will be of interest to the community, particularly those studying dopamine. The model simulations provide convincing evidence for differences between dorsal and ventral striatum dopamine concentrations, while evidence for differential tracking of dopamine changes by D1 vs D2 receptors is solid.

Reviewer #1 (Public review):

Anonymous

Ejdrup, Gether and colleagues present a sophisticated simulation of dopamine (DA) dynamics based on a substantial volume of striatum with many DA release sites. The key observation is that reduced DA uptake rate in ventral striatum (VS) compared to dorsal striatum (DS) can produce an appreciable "tonic" level of DA in VS and not DS. In both areas they find that a large proportion of D2 receptors are occupied at "baseline"; this proportion increases with simulated DA cell phasic bursts but has little sensitivity to simulated DA cell pauses. They also examine, in a separate model, the effects of clustering dopamine transporters (DAT) into nanoclusters and say this may be a way of regulating tonic DA levels in VS. I found this work of interest and I think it will be useful to the community.

The conclusion that even an unrealistically long (1s) and complete pause in DA firing has little effect on DA receptor occupancy is potentially very important. The ability to respond to DA pauses has been thought to be a key reason why D2 receptors (may) have high affinity. This simulation instead finds evidence that DA pauses may be useless, from the perspective of reward prediction error signals.

Reviewer #2 (Public review):

Anonymous

The work presents a model of dopamine release, diffusion and reuptake in a small (100 micrometer^2 maximum) volume of striatum. This extends previous work by this group and others by comparing dopamine dynamics in the dorsal and ventral striatum and by using a model of immediate dopamine-receptor activation inferred from recent dopamine sensor data. From their simulations the authors report three main conclusions: that ventral and dorsal striatum have consistently different distributions of dopamine; that dorsal striatum does not appear to have a clear "tonic" dopamine -- the sustained, relatively uniform concentration of dopamine driven by the constant 4Hz firing of dopamine neurons; and that D1 receptor activation is able to track rapid increases in dopamine concentration changes D2 receptor activation cannot -- and neither receptor-type's activation tracks pauses in pacemaker firing of dopamine neurons.

The simulations of dorsal striatum will be of interest to dopamine aficionados as they throw doubt on the classic model of "tonic" and "phasic" dopamine actions, further show the disconnect between dopamine neuron firing and consequent release, and thus raise issues for the reward-prediction error theory of dopamine.

There is some careful work here checking the dependence of results on the spatial volume and its discretisation. The simulations of dopamine concentration from pacemaker firing of dopamine neurons are checked over a range of values for key parameters. The model is good, the simulations are well done, and the evidence for robust differences between dorsal and ventral striatum dopamine concentration is good.

There are a couple of weaknesses that suggest further work is needed to support the third conclusion of how DA receptors track dopamine concentration changes, before any strong conclusions are drawn about the implications for the reward prediction error theory of dopamine:

effects of changes in affinity (EC50) are tested, and shown to be robust, but not of the receptors' binding (k_on) and unbinding (k_off) rate constants which are more crucial in setting the ability to track changes in concentration.

bursts of dopamine were modelled as release from a cluster of local release sites (40), which is consistent with induced local release by e.g. cholinergic receptor activation, but the rate of release was modelled as the burst firing of dopamine neurons. Burst firing of dopamine neurons would produce a wide range of release site distributions, and are unlikely to be only locally clustered. Conversely, pauses in dopamine release were seemingly simulated as a blanket cessation of activity at all release sites, which implies a model of complete correlation between dopamine neurons. It would be good to have seen both release scenarios for both types of activity, as well as more nuanced models of phasic firing of dopamine neurons.

That said, in releasing their code openly the authors have made it possible for others to extend this work to test the rate constants, the modelling of dopamine neuron bursting, and more.

eLife. 2026 Jan 23;14:RP105214. doi: 10.7554/eLife.105214.3.sa3

Author response

Aske Ejdrup 1, Jakob Kisbye Dreyer 2, Matthew D Lycas 3, Søren H Jørgensen 4, Trevor W Robbins 5, Jeff Dalley 6, Freja Herborg 7, Ulrik Gether 8

The following is the authors’ response to the original reviews.

Reviewer #1 (Public review):

“Ejdrup, Gether, and colleagues present a sophisticated simulation of dopamine (DA) dynamics based on a substantial volume of striatum with many DA release sites. The key observation is that a reduced DA uptake rate in the ventral striatum (VS) compared to the dorsal striatum (DS) can produce an appreciable "tonic" level of DA in VS and not DS. In both areas they find that a large proportion of D2 receptors are occupied at "baseline"; this proportion increases with simulated DA cell phasic bursts but has little sensitivity to simulated DA cell pauses. They also examine, in a separate model, the effects of clustering dopamine transporters (DAT) into nanoclusters and say this may be a way of regulating tonic DA levels in VS. I found this work of interest and I think it will be useful to the community. At the same time, there are a number of weaknesses that should be addressed, and the authors need to more carefully explain how their conclusions are distinct from those based on prior models.

We appreciate that the reviewer finds our work interesting and useful to the community. However, we acknowledge it is important to discuss how our conclusions are different from those reached based on previous model. Already in the original version of the manuscript we discussed our findings in relation to earlier models; however, this discussion has now been expanded. In particular, we would argue that our simulations, which included updated parameters, represent more accurate portrayals of in vivo conditions as it is now specifically stated in lines 466-487. Compared to previous models our data highlight the critical importance of different DAT expression across striatal subregions as a key determinant of differential DA dynamics and differential tonic levels in DS compared to VS. We find that these conclusions are already highlighted in the Abstract and Discussion.

(1) The conclusion that even an unrealistically long (1s) and complete pause in DA firing has little effect on DA receptor occupancy is potentially important. The ability to respond to DA pauses has been thought to be a key reason why D2 receptors (may) have high affinity. This simulation instead finds evidence that DA pauses may be useless. This result should be highlighted in the abstract and discussed more.“

This is an interesting point. We have accordingly carried out new simulations across a range of D2R affinities to assess how this will affect the finding that even a long pause in DA firing has little effect on DR2 receptor occupancy. Interestingly, the simulations demonstrate that this finding is indeed robust across an order of magnitude in affinity, although the sensitivity to a one-second pause goes up as the affinity reaches 20 nM. The data are shown in a revised Figure S1H. For description of the results, please see revised text lines 195-197. The topic is now mentioned in the abstract as well as further commented in the Discussion in lines 500-504.

“(2) The claim of "DAT nanoclustering as a way to shape tonic levels of DA" is not very well supported at present. None of the panels in Figure 4 simply show mean steady-state extracellular DA as a function of clustering. Perhaps mean DA is not the relevant measure, but then the authors need to better define what is and why. This issue may be linked to the fact that DAT clustering is modeled separately (Figure 4) to the main model of DA dynamics (Figures 1-3) which per the Methods assumes even distribution of uptake. Presumably, this is because the spatial resolution of the main model is too coarse to incorporate DAT nanoclusters, but it is still a limitation.”

We agree with the reviewer that steady-state extracellular DA as a function of DAT clustering is a useful measure. We have therefore simulated the effects of different nanoclustering scenarios on this measure. We found that the extracellular concentrations went from approximately 15 nM for unclustered DAT to more than 30 nM in the densest clustering scenario. These results are shown in revised Figure 4F and described in the revised text in lines 337-349.

Further, we fully agree that the spatial resolution of the main model is a limitation and, ideally, that the nanoclustering should be combined with the large-scale release simulations. Unfortunately, this would require many orders of magnitude more computational power than currently available.

“As it stands it is convincing (but too obvious) that DAT clustering will increase DA away from clusters, while decreasing it near clusters. I.e. clustering increases heterogeneity, but how this could be relevant to striatal function is not made clear, especially given the different spatial scales of the models.”

Thank you for raising this important point. While it is true that DAT clustering increases heterogeneity in DA distribution at the microscopic level, the diffusion rate is, in most circumstances, too fast to permit concentration differences on a spatial scale relevant for nearby receptors. Accordingly, we propose that the primary effect of DAT nanoclustering is to decrease the overall uptake capacity, which in turn increases overall extracellular DA concentrations. Thus, homogeneous changes in extracellular DA concentrations can arise from regulating heterogenous DAT distribution. An exception to this would be the circumstance where the receptor is located directly next to a dense cluster – i.e. within nanometers. In such cases, local DA availability may be more directly influenced by clustering effects. Please see revised text in lines 354-362 for discussion of this matter.

“(3) I question how reasonable the "12/40" simulated burst firing condition is, since to my knowledge this is well outside the range of firing patterns actually observed for dopamine cells. It would be better to base key results on more realistic values (in particular, fewer action potentials than 12).”

We fully agree that this typically is outside the physiological range. The values are included in addition to more realistic values (3/10 and 6/20) to showcase what extreme situations would look like.

“(4) There is a need to better explain why "focality" is important, and justify the measure used.”

We have expanded on the intention of this measure in the revised manuscript (please see lines 266-268). Thank you for pointing out this lack of clarification.

“(5) Line 191: " D1 receptors (-Rs) were assumed to have a half maximal effective concentration (EC50) of 1000 nM" The assumptions about receptor EC50s are critical to this work and need to be better justified. It would also be good to show what happens if these EC50 numbers are changed by an order of magnitude up or down.”

We agree that these assumptions are critical. Simulations on effective off-rates across a range of EC50 values has now been included in the revised version in Figure 1I and is referred to in lines 188-189.

“(6) Line 459: "we based our receptor kinetics on newer pharmacological experiments in live cells (Agren et al., 2021) and properties of the recently developed DA receptor-based biosensors (Labouesse & Patriarchi, 2021). Indeed, these sensors are mutated receptors but only on the intracellular domains with no changes of the binding site (Labouesse & Patriarchi, 2021)"

This argument is diminished by the observation that different sensors based on the same binding site have different affinities (e.g. in Patriarchi et al. 2018, dLight1.1 has Kd of 330nM while dlight1.3b has Kd of 1600nM).”

We sincerely thank the reviewer for highlighting this important point. We fully recognize the fundamental importance of absolute and relative DA receptor kinetics for modeling DA actions and acknowledge that differences in affinity estimates from sensor-based measurements highlight the inherent uncertainty in selecting receptor kinetics parameters. While we have based our modeling decisions on what we believe to be the most relevant available data, we acknowledge that the choice of receptor kinetics is a topic of ongoing debate. Importantly, we are making our model available to the research community, allowing others to test their own estimates of receptor kinetics and assess their impact on the model’s behavior. In the revised manuscript, we have further elaborated the rationale behind our parameter choices. Please see revised text in lines in lines 177-178 of the Results section and in lines 481-486 of the Discussion.

“(7) Estimates of Vmax for DA uptake are entirely based on prior fast-scan voltammetry studies (Table S2). But FSCV likely produces distorted measures of uptake rate due to the kinetics of DA adsorption and release on the carbon fiber surface.”

We fully agree that this is a limitation of FSCV. However, most of the cited papers attempt to correct for this by way of fitting the output to a multi-parameter model for DA kinetics. If newer literature brings the Vmax values estimated into question, we have made the model publicly available to rerun the simulations with new parameters.

“(8) It is assumed that tortuosity is the same in DS and VS - is this a safe assumption?”

The original paper cited does not specify which region the values are measured in. However, a separate paper estimates the rat cerebellum has a comparable tortuosity index (Nicholson and Phillips, J Physiol. 1981), suggesting it may be a rather uniform value across brain regions. This is now mentioned in lines 98-99 and the reference has been included.

“(9) More discussion is needed about how the conclusions derived from this more elaborate model of DA dynamics are the same, and different, to conclusions drawn from prior relevant models (including those cited, e.g. from Hunger et al. 2020, etc)”.

As part of our revision, we have expanded the current discussion of our finding in the context of previous models in the manuscript in lines 466-487.

Reviewer #2 (Public review):

The work presents a model of dopamine release, diffusion, and reuptake in a small (100 micrometers^2 maximum) volume of striatum. This extends previous work by this group and others by comparing dopamine dynamics in the dorsal and ventral striatum and by using a model of immediate dopamine-receptor activation inferred from recent dopamine sensor data. From their simulations, the authors report two main conclusions. The first is that the dorsal striatum does not appear to have a sustained, relatively uniform concentration of dopamine driven by the constant 4Hz firing of dopamine neurons; rather that constant firing appears to create hotspots of dopamine. By contrast, the lower density of release sites and lower rate of reuptake in the ventral striatum creates a sustained concentration of dopamine. The second main conclusion is that D1 receptor (D1R) activation is able to track dopamine concentration changes at short delays but D2 receptor activation cannot.

The simulations of the dorsal striatum will be of interest to dopamine aficionados as they throw some doubt on the classic model of "tonic" and "phasic" dopamine actions, further show the disconnect between dopamine neuron firing and consequent release, and thus raise issues for the reward-prediction error theory of dopamine.

There is some careful work here checking the dependence of results on the spatial volume and its discretisation. The simulations of dopamine concentration are checked over a range of values for key parameters. The model is good, the simulations are well done, and the evidence for robust differences between dorsal and ventral striatum dopamine concentration is good.

However, the main weakness here is that neither of the main conclusions is strongly evidenced as yet. The claim that the dorsal striatum has no "tonic" dopamine concentration is based on the single example simulation of Figure 1 not the extensive simulations over a range of parameters. Some of those later simulations seem to show that the dorsal striatum can have a "tonic" dopamine concentration, though the measurement of this is indirect. It is not clear why the reader should believe the example simulation over those in the robustness checks, for example by identifying which range of parameter values is more realistic.”

We appreciate that the reviewer finds our work interesting and carefully performed.The reviewer is correct that DA dynamics, including the presence and level of tonic DA, are parameter-dependent in both the dorsal striatum (DS) and ventral striatum (VS). Indeed, our simulations across a broad range of biological parameters were intended to help readers understand how such variation would impact the model’s outcomes, particularly since many of the parameters remain contested. Naturally, altering these parameters results in changes to the observed dynamics. However, to derive possible conclusions, we selected a subset of parameters that we believe best reflect the physiological conditions, as elaborated in the manuscript. In response to the reviewer’s comment, we have placed greater emphasis on clarifying which parameter values we believe reflect the physiological conditions the most (see lines 155-157 and 254-255). Additionally, we have underscored that the distinction between tonic and non-tonic states is not a binary outcome but a parameter-dependent continuum (lines 222-225)—one that our model now allows researchers to explore systematically. Finally, we have highlighted how our simulations across parameter space not only capture this continuum but also identify the regimes that produce the most heterogeneous DA signaling, both within and across striatal regions (lines 266-268).

“The claim that D1Rs can track rapid changes in dopamine is not well supported. It is based on a single simulation in Figure 1 (DS) and 2 (VS) by visual inspection of simulated dopamine concentration traces - and even then it is unclear that D1Rs actually track dynamics because they clearly do not track rapid changes in dopamine that are almost as large as those driven by bursts (cf Figure 1i).”

We would like to draw the attention to Figure 1I, where the claim that D1R track rapid changes is supported in more depth (Figure S1 in original manuscript - moved to main figure to highlight this in the revised manuscript). According to this figure, upon coordinated burst firing, the D1R occupancy rapidly increased as diffusion no longer equilibrated the extracellular concentrations on a timescale faster than the receptors – and D1R receptor occupancy closely tracked extracellular DA with a delay on the order of tens of milliseconds. Note that the brief increases in [DA] from uncoordinated stochastic release events from tonic firing in Figure 1H are too brief to drive D1 signaling, as the DA concentration diffuses into the remaining extracellular space on a timescale of 1-5 ms. This is faster than the receptors response rate and does not lead to any downstream signaling according to our simulations. This means D1 kinetics are rapid enough to track coordinated signaling on a ~50 ms timescale and slower, but not fast enough to respond to individual release events from tonic activity.

“The claim also depends on two things that are poorly explained. First, the model of binding here is missing from the text. It seems to be a simple bound-fraction model, simulating a single D1 or D2 receptor. It is unclear whether more complex models would show the same thing.”

We realize that this is not made clear in the methods and, accordingly, we have updated the method section to elaborate on how we model receptor binding. The model simulates occupied fraction of D1R and D2R in every single voxel of the simulation space. Please see lines 546-555.

“Second, crucial to the receptor model here is the inference that D1 receptor unbinding is rapid; but this inference is made based on the kinetics of dopamine sensors and is superficially explained - it is unclear why sensor kinetics should let us extrapolate to receptor kinetics, and unclear how safe is the extrapolation of the linear regression by an order of magnitude to get the D1 unbinding rate.”

We chose to use the sensors because it was possible to estimate precise affinities/off-rates from the fluorescent measurements. Although there might some variation in affinities that could be attributable to the mutations introduced in the sensors, the data clearly separated D1R and D2R with a D1R affinity of ~1000 nM and a D2R affinity of ~7 nM (Labouesse & Patriarchi, 2021) consistent with earlier predictions of receptor affinities. From our assessment of the literature, we found that this was the most reasonable way to estimate affinities and thereby off-rates. Importantly, the model has been made publicly available, so should new measurements arise, the simulations can be rerun with tweaks to the input parameters. To address the concern, we have also expanded a bit on the logic applied in the updated manuscript (please see lines 177-178).

Reviewing editor Comments :

The paper could benefit from a critical confrontation not only with existing modeling work as mentioned by the reviewers, but also with existing empirical data on pauses, D2 MSN excitability, and plasticity/learning.”

We thank both the editor and the reviewers for their suggestions on how to improve the manuscript. We have incorporated further modelling on D1R and D2R response to pauses and bursts and expanded our discussion of the results in relation to existing evidence (please see our responses to the reviewers above and the revised text in the manuscript).

Reviewer #1 (Recommendations for the authors):

“(1) Many figure panels are too small to read clearly - e.g. "cross-section over time" plots.”

We agree with the reviewer and have increased the size of panels in several of the figures.

(2) Supplementary Videos of the model in action might be useful (and fun to watch).”

Great idea. We have generated videos of both bursts in the 3D projections and the resulting D1R and D2R occupancy in 2D. The videos are included as supplementary material as Videos S1 and S2 and referred to in the text of the revised manuscript.

” (3) Line 305: " Further, the cusp-like behaviour of Vmax in VS was independent of both Q and R%..."

It is not clear what the "cusp" refers to here.”

We agree this is a confusing sentence. We have rewritten and eliminated the use of the vague “cusp” terminology in the manuscript.

” (4) Line 311: "We therefore reanalysed data from our previously published comparison of fibre photometry and microdialysis and found evidence of natural variations in the release-uptake balance of the mice (Figure 5F,G)" This figure seems to be missing altogether.”

The manuscript missed “S” in the mentioned sentence to indicate a supplementary figure. We apologies for the confusion and have corrected the text.

(5) Figure 1:

1b: need numbers on the color scale.”

We have added numbers in the updated manuscript.

”1c: adding an earlier line (e.g. 2ms) could be helpful?”

We have added a 2 ms line to aid the readers.

”1d: do the colors show DA concentration on the visible surfaces of the cube or some form of projection?”

The colors show concentrations on the surface. We have expanded the text to clarify this.

”1e: is this "cross-section" a randomly-selected line (i.e. 1D) through the cube?”

The cross-section is midway through the cube. We have clarified this in the text.

”1f: "density" misspelled.”

We thank the reviewer for the keen eye. The error has been corrected.

”1g: color bars indicating stimulation time would be improved if they showed the individual stimulation pulses instead.”

The burst is simulated as a Poisson distribution and individual pulses may therefore be misleading.

” Why does the burst simulation include all release sites in a 10x10x10µm cube? Please justify this parameter choice.

1h: "1/10" - the "10" is meaningless for a single pulse, right?”

Yes, we agree.

”1i: is this the concentration for a single voxel? Or the average of voxels that are all 1µm from one specific release site?”

Thank you for pointing out the confusing language. The figure is for a voxel containing a release site (with a voxel size of 1 um in diameter).

The legend seems a bit different from the description in the main text ("within 1µm"). As it stands, I also can't tell whether the small DA peaks are related to that particular release site, or to others.

We have updated the text to clear up the confusing language.

” (6) Figure 2:

2h: I'm not sure that the "relative occupancy" normalized measure is the most helpful here.”

We believe the figure aids to illustrate the sphere of influence on receptors from a single burst is greater in VS than DS, suggesting DS can process information with tighter spatial control. Using a relative measure allows for more accessible comparison of the sphere of influence in a single figure.

” (7) Figure 3:

The schematics need improvement.

3a – would be more useful if it corresponded better to the actual simulation (e.g. we had a spatial scale shown).

3d – is this really useful, given the number of molecules shown is so much lower than in the simulation?

3h, 3j – need more explanation, e.g. axis labels. ”

The schematics are intended to quickly inform the readers what parameters are tuned in the following figures, and not to be exact representations. However, we agree Figures 3h and 3j need axis labels, and we have accordingly added these.

(8) Figure 4:

4m, n were not clearly explained.

We agree and have elaborated the explanation of these figures in the manuscript (lines 374-377).

” (9) From Figure S1 it appears that the definition of "DS" and "VS" used is above and below the anterior commissure, respectively. This doesn't seem reasonable - many if not most studies of "VS" have examined the nucleus accumbens core, which extends above the anterior commissure. Instead, it seems like the DAT expression difference observed is primarily a difference between accumbens Shell and the rest of the striatum, rather than DS vs VS.”

We assume that the reviewer refers to Figure S3 and not S1. First, we would like to highlight that we had mislabeled VMAT2 and DAT in Figure S3C (now corrected). Apologies for the confusion. Second, as for striatal subregions, we have intentionally not distinguished between different subregions of the ventral striatum. The majority of literature we base our parameters on do not specify between e.g., NAcC vs. NAcS or DLS vs. DMS. The four slices we examined in Figure 3A-C were not perfectly aligned in the accumbal region, and we therefore do not believe we can draw any conclusions between core and shell.

Reviewer #2 (Recommendations for the authors):

(1) Modelling assumptions:

The burst activity simulations seem conceptually flawed. How were release sites assigned to the 150 neurons? The burst activity simulations such as Figure 1g show a spatially localised release, but this means either (1) the release sites for one DA neuron are all locally clustered, or (2) only some release sites for each DA neuron are receiving a burst of APs, those release sites are close together, and the DA neurons' other release sites are not receiving the burst. Either way, this is not plausible.”

We apologize for the confusion; however, we disagree that the simulations seem conceptually flawed. It is important to note that the burst simulation is spatially restricted to investigate local DA dynamics and how well different parts of the striatum can gate spill-over and receptor activation. The conditions may mimic local action potentials generated by nicotinic receptor activation (see e.g. Liu et al. Science 2022 or Matityahu et al, Nature Comm 2023), We have accordingly expanded on this is the manuscript on lines 148-151.

(2) Data and its reporting:

Comparison to May and Wightman data: if we're meant to compare DS and VS concentrations, then plot them together; what were the experimental results (just says "closely resembled the earlier findings")?”

Unfortunately, the quantitative values of the May and Wightman (1989) data are not publicly available. We are therefore limited to visual comparison and cannot replot the values.

” Figures S3b and c do not agree: Figure S3b shows DAT staining dropping considerably in VS; Fig 3c does not, and neither do the quoted statistics.”

We had accidentally mixed up the labels in Figure S3c. Thank you for spotting this. We have corrected this in the updated manuscript.

” How robust are the results of simulations of the same parameter set? Figures S3D and E imply 5 simulations per burst paradigm, but these are not described.”

The bursts are simulated with a Poisson distribution as described in Methods under Three-dimensional finite difference model. This induces a stochastic variation in the simulations that mimics the empirical observations (see Dreyer et al., J. Neurosci., 2010).

” I found it rather odd that the robustness of the receptor binding results is not checked across the changes in model parameters. This seems necessary because most of the changes, such as increasing the quantal release or the number of sites, will obviously increase dopamine concentration, but they do not necessarily meaningfully increase receptor activation because of saturation (and, in more complex receptor binding models, because of the number of available receptors).”

This is an excellent point. However, we decided not to address this in the present study as we would argue that such additional simulations are not a necessity for our main conclusions. Instead, we decided in the revised version to focus on simulations mirroring a range of different receptor affinities as described in detail above.

” Figure 4H: how can unclustered simulations have a different concentration at the centre of a "cluster" than outside, when the uptake is homogenous? Why is clustering of DAT "efficient"? [line 359]”

This is a great observation. The drop is compared to the average of the simulation space. Despite no clusters, the uniform scenario still has a concentration gradient towards the surface of the varicosity. We have elaborated on this in the manuscript on lines 346-349.

” The Discussion conclusions about what D1Rs and D2Rs cannot track are not tested in the paper (e.g. ramps). Either test them or make clear what is speculation.”

An excellent point that some of the claims in the discussion were not fully supported. We have added a simulation with a chain of burst firings to highlight how the temporal integration differs between the two receptors and updated the wording in the discussion to exclude ramps as this was not explicitly tested. See lines 191-193 and Figure S1G.

” (3) Organisation of paper:

Consistency of terminology. These terms seem to be used to describe the same thing, but it is unclear if they are: release sites, active terminals (Table 1), varicosity density. Likewise: release probability, release fraction.”

Thank you for pointing this out. We have revised the manuscript and cleared up terminology on release sites. However, release probability and release-capable fraction of varicosities are two separate concepts.

” The references to the supplementary figure are not in sequence, and the panels assigned to the supplemental figures seem arbitrary in what is assigned to each figure and their ordering. As Figures 1 and 2 are to be directly compared, so plot the same results in each. Figure S1F is discussed as a key result, but is in a supplemental figure. ”

Thank you for identifying this. We have updated figure references and further moved Figure S1F into the main as we agree this is a main finding.

” The paper frequently reads as a loose collection of observations of simulations. For example, why look at the competitive inhibition of DA by cocaine [Fig 3H-I]? The nanoclustering of DAT (Figure 4) seems to be partial work from a different paper - it is unclear why the Vmax results warrant that detailed treatment here, especially as no rationale is offered for why we would want Vmax to change.”

We apologize if the paper reads as a loose collection of observations of simulations. This is certainly not the case. As for the cocaine competition, we used this because this modulates the Km value for DA and because we wanted to examine how dependent the dopamine dynamics are to changing different parameters in the model (Km in this case). We noticed Vmax had a separate effect between DS and VS. Accordingly, we gave it particular focus because it is physiological parameter than be modified and, if modified, it can have potential large impact on striatal DA dynamics. Importantly, it is well known that the DA transporter (DAT) is subject to cellular regulation of its surface expression e.g. by internalization /recycling and thereby of uptake capacity (Vmax). Furthermore, we demonstrate in the present study evidence that uptake capacity on a much faster time scale can be modulated by nanoclustering, which posits a potentially novel type of synaptic plasticity. We find this rather interesting and decided therefore to focus on this in the manuscript.

” What are the axes in Figure 3H and Figure 3J?”

We have updated the figures to include axis. Thank you for pointing out this omission.

” Much is made of the sensitivity to Vmax in VS versus DS, but this was hard work to understand. It took me a while to work out that Figure 3K was meant to indicate the range of Vmax that would be changed in VS and DS respectively. "Cusp-like behaviour" (line 305) is unclear.”

We agree that the original language was unclear – including the terminology “cusplike behavior”. We have updated the description and cut the confusion terminology. See line 366.

” The treatment of highly relevant prior work, especially that of Hunger et al 2020 and Dreyer et al (2010, 2014), is poor, being dismissed in a single paragraph late in the Discussion rather than explicating how the current paper's results fit into the context of that work. The authors may also want to discuss the anticipation of their conclusions by Wickens and colleagues, including dopamine hotspots (https://doi.org/10.1016/j.tins.2006.12.003) and differences between DS and VS dopamine release (https://doi.org/10.1196/annals.1390.016).”

We thank the reviewer for the suggested discussion points and have included and discussed references to the work by Wickens and colleagues (see lines 407-411 and 418-420).

” (4) Methods:

Clarify the FSCV simulations: the function I_FSCV was convolved with the simulated [DA] signal?”

Yes. We have clarified this in the method section on lines 593-594.

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Data Citations

    1. Aske E. 2025. Data for the paper "Computational modelling identifies key determinants of subregion-specific dopamine dynamics in the striatum", Ejdrup et. al, 2025. Zenodo. [DOI] [PMC free article] [PubMed]

    Supplementary Materials

    Figure 1—source code 1. Source code used to generate data in A, D, E, and F.
    Figure 1—source code 2. Source code used to generate data in B and C.
    Figure 1—source code 3. Source code used to generate data in G.
    Figure 1—source code 4. Source code used to generate data in J.
    Figure 1—source code 5. Source code used to generate data in H.
    Figure 1—source code 6. Source code used to generate data in I.
    Figure 1—figure supplement 1—source code 1. Source code used to generate data in Figure 1—figure supplement 1.
    Figure 1—figure supplement 2—source code 1. Source code used to generate data in Figure 1—figure supplement 2.
    Figure 2—source code 1. Source code used to generate data in A-F.
    Figure 2—source code 2. Source code used to generate data in G and H.
    Figure 3—source code 1. Source code used to generate data in B, C, E-G.
    Figure 3—source code 2. Source code used to generate data in I.
    Figure 3—source code 3. Source code used to generate data in K and L.
    Figure 3—figure supplement 1—source code 1. Source code used to generate data in Figure 3—figure supplement 1.
    Figure 3—figure supplement 2—source code 1. Source code used to generate data in Figure 3—figure supplement 2A-D.
    Figure 4—source code 1. Source code for simulation.
    Figure 4—source code 2. Source code used to generate data in A-E and G-I.
    Figure 4—source code 3. Source code used to generate data in F.
    MDAR checklist

    Data Availability Statement

    Numerical implementation and code to run the simulations in a Jupyter notebook format are available at: https://github.com/GetherLab/striatal-dopamine-modelling (copy archived at Ejdrup, 2024) or in the source code files accompanying the article in .Py format. The data for Figure 4 can be simulated with the provided source code (Figure 4—source code 1) or found at https://doi.org/10.5281/zenodo.18046987 alongside the data for Figure 2—figure supplement 1. The localization files for all dSTORM image analyzed in the paper can also be found at https://doi.org/10.5281/zenodo.18046987. These .txt files contain all the necessary data for the analyses conducted and can be used in combination with the drift correction files also uploaded to recreate the images.

    The following dataset was generated:

    Aske E. 2025. Data for the paper "Computational modelling identifies key determinants of subregion-specific dopamine dynamics in the striatum", Ejdrup et. al, 2025. Zenodo.


    Articles from eLife are provided here courtesy of eLife Sciences Publications, Ltd

    RESOURCES